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Neutrophils are one of the most effective antimicrobial cells in the innate immune system. They 
arrive at a site of infection or inflammation in response to a chemotactic gradient. At this site, 
they phagocytose invading pathogens and aid in their destruction through both oxidative and 
non-oxidative mechanisms. This is known to be mediated through the release of toxic granule 
contents and antimicrobial effector proteins. After their antimicrobial activity is performed, 
neutrophils undergo a programmed cell death process known as apoptosis and are quickly 
cleared from sites of inflammation by phagocytes. As such, neutrophils are believed to be fast-
acting, short-living effector cells that perform antimicrobial activities with limited influence on 
ensuing immune responses.  
 
Nevertheless, neutrophils are increasingly being shown to be regulators of adaptive immune 
responses. I show that neutrophils can act as professional antigen presenting cells capable of 
processing and presenting antigen to T cells. I also show that acquisition of antigen presentation 
ability is T cell-contact dependent and that the resulting T cell response is skewed towards a Th1 
and Th17 phenotype. 
 
Neutrophils also have the ability to undergo a cell death process termed NETosis in which they 
extrude extracellular DNA that can trap and kill pathogens. I show that both mouse and human 
neutrophils undergo NETosis in response to the protozoan parasite Toxoplasma gondii and that 
the resulting entrapment leads to parasite killing. NETosis in response to Toxoplasma is parasite-
invasion independent and is mediated partly by signaling through the ERK pathway. 
 
The in vivo role of neutrophils during a Toxoplasma infection was also addressed. I show that 
neutrophil depleted and infected mice succumb to infection with highly dysregulated pulmonary 
immune responses. Depletion of neutrophils led to an increased phagocyte inflammatory state 
that resulted in an increase in T cell activity and cytokine production leading to pathology and 
ultimately death of the host. 
 
Data presented in this thesis challenge the traditional view of neutrophils and portray them more 
as immunoregulatory cells that can influence, shape, and regulate an immune response well 
beyond the stages of innate immunity and even beyond their own death. 
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INTRODUCTION 
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Toxoplasma 
Discovery, history and life cycle of Toxoplasma gondii 
Toxoplasma gondii is an obligate intracellular protozoan parasite belonging to the phylum 
Apicomplexa, subclass coccidian (1). It is a ubiquitous parasite that was discovered about 100 
years ago by two different independent research groups. Charles Nicolle and Louis Manceaux 
discovered Toxoplasma in 1908 in tissues of a North African hamster-like rodent (Ctenodactylus 
gundi) in Tunis, while Alfonso Splendore discovered it, also in 1908, in a rabbit in Brazil (2, 3). 
The parasite has since been found to infect most if not all warm-blooded animals and has been 
described as one of the most successful parasitic organisms worldwide (4). 
 
The parasite has the ability to infect a wide range of intermediate hosts, but it was not until 1965 
that its definitive host was identified as the cat (5). A few years later, in 1970, the definitive host 
cycle was elucidated following discoveries that the sexual development stages occurred in the 
small intestine of the cat (4, 6, 7). The infectious agents of T. gondii for all hosts have been 
defined to belong to either one of the following life cycle stages: tachyzoites, bradyzoites 
(contained in tissue cysts) or sporozoites (contained in oocysts). After ingestion of tissue cysts or 
oocysts, the bradyzoites or sporozoites transform into rapidly dividing tachyzoites that can 
invade and infect virtually any nucleated cell. The tachyzoite is most often seen as crescent 
shaped and will enter a host cell through a process that involves active invasion and will divide 
within a host cell by multiplying asexually by repeated endodyogeny until the host cell runs out 
of intracellular space and ruptures as a result. Host cell invasion by toxoplasma is parasite 
mediated and once inside the cell, the parasite resides in a parasitophorous vacuole (PV) that is 
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protected from host cell killing mechanisms. The PV is formed by invagination of the host cell 
membrane but at the same time excludes most transmembrane proteins (8, 9). The PV has a 
nonfusigenic nature and thus it remains segregated from both the exocytic  and endocytic  
pathways of the host cell (10). This active invasion is essential for survival of the parasite since 
phagocytosis of antibody opsonized parasites leads to the incorporation of the parasite into the 
phagosomal maturation pathway eventually killing the parasite (11). After a number of divisions 
occur, a tachyzoite will give rise to a tissue cyst full of bradyzoites that is characterized by its 
dormant nature in muscular and neural tissues. These cysts are usually harmless and can persist 
for the life of the host and can be found in almost all intermediate hosts (12). Oocysts are shed by 
cats after ingesting any of the three infectious stages of T. gondii. The most common route of 
infection in cats is the ingestion of tissue cysts, after which the cyst wall is broken down by 
enzymes in the stomach and small intestine, where bradyzoites are released and infect small 
intestine epithelial cells (13). Five distinct morphological stages of T. gondii, defined as types A 
to E schizonts, occur before the parasite enters its sexual stages to produce oocysts (14). Felines 
shed Toxoplasma in their feces in the form of non-infective, unsporulated oocysts that become 
sporulated and infective in the environment. Each sporulated oocyst contains 2 elliptically 
shaped sporocysts, each containing 4 sporozoites. Feline shed oocysts are extremely resistant to 
harsh environmental conditions and are able to survive in fresh/seawater, soil, and can persist 
even after chemical and physical treatment of contaminated water including chlorination, 
ultraviolet rays and ozone treatment (refer to Figure 1.1 for a life cycle) (15, 16). 
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Toxoplasmosis in humans and animals 
T. gondii is the causative agent for the disease Toxoplasmosis and is one of the most prevalent 
protozoan parasitic infectious agents in man and mammals. It is observed that the seroprevalence 
rates for both humans and animals can vary widely between geographic locations dues to various 
factors including but not limited to food consumption behaviors, food production practices, 
governmental control and safety procedures as well as animal-related hygiene. In humans, 
seroprevalence can be as high as 16-40 % in the Unites States, and 50-80 % in South America 
and continental Europe (17). It is important to note that the seroprevalence in humans has been 
steadily declining over the past few decades (18, 19). 
 
In humans, acute T. gondii infection is mostly asymptomatic in immunocompetent adults and 
children but can cause severe disease in immunocompromised hosts, most notably in individuals 
with Acquired Immune Deficiency Syndrome (AIDS). The most common clinical manifestation 
of T. gondii in AIDS patients is encephalitis due to the reactivation of the parasite during latent 
infections (20). In the United States, anywhere from 10% to 40% of adults with AIDS are 
latently infected with T. gondii and about one third of these patients will develop toxoplasmic 
encephalitis (21). Toxoplasma infection also poses a serious risk for fetuses if the infection is 
acquired during gestation. Depending upon the stage of pregnancy, congenital infection can have 
different subclinical or clinically apparent outcomes. Infections occurring in the first trimester 
are generally more severe than infections acquired in the second or third trimester, while 
infections acquired before gestation normally pose little or no risk at all (1, 22). Infection during 
gestation can result in visual and hearing losses, mental retardation and sometimes death, with 
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the most common manifestation of infection being ocular disease (23). The major sources of 
parasite in postnatally acquired infections is through the ingestion of tissue cysts present in 
undercooked meat or by consumption of contaminated water or food by oocysts shed in cat feces 
(17). Another rare but important source of infection is by organ transplantation or blood 
transfusions between an infected and a non-infected individual (1, 24). These types of infected 
individuals are at high risk of cyst recrudescence due to the fact that they are under an 
immunosuppressive regimen of drugs. One also has to take into consideration the potential for 
possible infection with the parasite in laboratory personnel due to the exposure to infected 
needles, glassware or even animals. 
 
In addition to its relevance in humans, Toxoplasma has been found to infect a wide range of 
animals ranging from domestic animals, wild animals, fur-bearing carnivores, wild felids, wild 
pigs, sea mammals, monkeys, marsupials, ungulates and even birds (25). The parasite is known 
to cause major agricultural economic losses especially in goats and sheep where millions of 
lambs are lost yearly throughout the world due to Toxoplasma induced abortions (26). The 
emergence of infections in marine mammals is a more recent development in the epidemiology 
of Toxoplasma where reports are surfacing of infections in otters, seals, sea lions and dolphins 
(27-29). It is postulated that coastal pollution by run-off from contaminated freshwater or sewage 
as a result of human or pet activity might be the source of Toxoplasma infections in marine 
mammals. As a result, filtration of water by shellfish can take place leading to a highly 
concentrated amount of oocysts in these shellfish that in turn become a source of infection in the 
marine environment (25, 30). 
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Figure 1.1 Toxoplasma gondii life cycle. Cats shed unsporulated oocysts in their feces (1) which 
can sporulate and become infective in the environment (2). Cats can then be re-infected by 
ingestion of sporulated oocysts (3). Cats can also ingest tissues cysts (5) found in intermediate 
host that had ingested sporulated oocysts (4). Also, humans may be infected by ingesting 
sporulated oocysts (8) or tissues cysts (7) from infected intermediated hosts that had ingested 
sporulated oocysts (6). Infected pregnant women can infect their fetuses through transplacental 
infections (9) and Toxoplasma-negative blood or organ recipients can get infected with the 
parasite if their donor is Toxoplasma-positive (10). 
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Diagnosis, treatment and prevention of T. gondii 
Various techniques have been developed over the years to aid in the determination of whether an 
individual or a particular animal is positive for Toxoplasma or not. T. gondii can be directly 
detected in tissues of infected hosts or indirectly diagnosed using serological methods. The Sabin 
and Feldman dye test was developed in 1948 to detect Toxoplasma antibodies in patient sera that 
can react with tachyzoites (31). Since then, other methods have been developed to diagnose 
seropositivity such as ELISA, IgG avidity test and agglutination (32-35). Parasites can also be 
directly detected in tissues through simple immunohistochemical procedures using widely 
available anti-toxoplasma antibodies or even a simple Giemsa stain or through PCR of the highly 
repetitive B1 Toxoplasma gene (36). 
 
Guidelines for the treatment of T. gondii infection have been established over the years. The 
regimen of drugs most often prescribed entails a combination of pyrimethamine, sulfadiazine and 
folinic acid (37). This regimen can vary depending on the infected host and stage of infection. 
For example, acute toxoplasmosis in women is often treated with spiramycin in the first 
trimester. AIDS patients with acute toxoplasmic encephalitis are sometimes treated with 
clindamycin instead of sulfadiazine. However, a regimen of pyrimethamine and sulfadiazine 
supplemented with folinic acid remains the gold standard for non-difficult cases and is 
administered for the duration of clinical symptoms and is continued for 1-2 weeks after the 
resolution of symptoms (1). It is important to note that this combination of drugs is only effective 
against the actively dividing, acute stage of infection and normally have no bearing on the 
dormant, chronic phase of toxoplasmosis (22).  
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Various preventative measures can be taken to inhibit infection in humans and animals of 
agricultural importance. Certain countries undertake a systematic screening of all pregnant 
women to minimize congenital infections and some advocate that pregnant women should be 
made aware of the dangers of congenital toxoplasmosis through routine obstetric care (1, 38). 
Simple hand washing and cooking techniques should be employed to effectively minimize 
human infections. Most infective stages of T. gondii are killed by exposure to extreme 
temperatures (hot or cold) and tissues cysts are also documented to be killed by gamma 
irradiation (22, 39). An effective vaccine against T. gondii licensed for human use has not been 
developed yet, however a vaccine against Toxoplasma in sheep has been developed using the 
attenuated live S48 strain of the parasite (40). Recent efforts in this regard have focused on 
vaccine candidates that can mimic the naturally occurring Th1 and humoral responses normally 
seen in humans after natural infections (1). Approaches have included using purified or 
recombinant parasite surface antigens, parasite secreted proteins (SAG-1/p30, MIC3), DNA 
vaccines and live attenuated or mutant forms of the parasite (CPS-1) (41-44). 
 
Taking into consideration all of the health hazards posed by the parasite and given its widespread 
prevalence in both the animal and human populations, it is vital to study the immune response to 
the parasite and to better understand its mechanism of disease induction in order to better 
formulate effective preventative and treatment measures, especially in humans. 
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Immunity to Toxoplasma gondii  
Toxoplasma is a ubiquitous intracellular parasite with three distinct clonal lineages, designated as 
Types I, II and III (45). Infection with Toxoplasma gondii induces a strong and persistent cell-
mediated immune response resulting in host protection (46). It is generally believed that once 
infection is established, the host is resistant to reinfection with the parasite (47). Cells of the 
innate immune system, most notably macrophages, dendritic cells and neutrophils are 
responsible for recognition of the parasite and subsequent production of cytokines and 
chemokines responsible for inducing protective responses in the host, most importantly IL-12 
and TNF-α production (48, 49). The production of IL-12 leads to the promotion of T-lymphocyte 
proliferation into Th1 IFN-γ producing cells and also has effects on induction of IFN- 
production by (natural killer) NK cells. Both IL-12 and IFN- are crucial for the control of the 
parasite, since depletion (or knock out) of either cytokine or depletion of both cytokines in vivo 
leads to uncontrolled parasite replication and infected animals die. IL-12 is absolutely critical for 
the induction of IFN- production, since in the absence of IL-12, IFN- production is impaired, 
while the absence of IFN- does not entirely abrogate IL-12 production (50). Additional 
evidence showing that these two cytokines are necessary for the control of Toxoplasma comes 
from studies showing that the administration of IL-12 and IFN- promotes survival of infected 
mice (51, 52). 
 
IFN-γ is generally viewed as the central mediator of host resistance to T. gondii  (53). This 
production of IFN-γ activates pathways in innate immune cells that lead to the killing and control 
of parasites. IFN- activated macrophages can become extremely potent cells with high 
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antimicrobial activity. Activated macrophages undergo nitric oxide (NO) production which leads 
to the destruction of the parasite. Also, IFN- activity on macrophages leads to the production of 
immunity-related GTPase (IRG) proteins also known as p47 GTPases and pathogen elimination 
is highly dependent on the IGTP IRG molecule. Killing mechanisms are thought to function by 
the localization of these proteins to the PV, followed by PV membrane indentation, vesiculation, 
disruption, stripping of the parasite plasma membrane and eventual fusion/delivery of the 
parasite to autophagosomes which ultimately fuse with lysosomes killing the parasite (refer to 
Figure 1.2)  (54, 55). 
 
The crucial importance of IFN- in the control of parasite replication and host survival is 
underscored by studies depleting T cells in Toxoplasma infected animals. Mice depleted of both 
CD4
+
 and CD8
+
 T cells undergo cyst reactivation and mice die from uncontrolled parasite 
replication (56). IFN- has also been shown to be crucial in the chronic and not just the acute 
phase of the infection since its continued presence can prevent toxoplasmic encephalitis in 
infected mice (57). In addition to antibody-mediated depletion of T cells, their importance in the 
course of a Toxoplasma infection is further demonstrated by infecting SCID mice (which lack B 
and T cells). These mice, although producers of IFN- through the activity of NK cells, still 
succumb to infection highlighting the importance of a continuous presence of CD4
+
 and CD8
+
 T 
cells (58). 
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Figure 1.2 (previous page). Immunity to Toxoplasma gondii. Cells of the innate immune 
system, such as DC, PMN and M, are responsible for the recognition of Toxoplasma (1). This 
recognition leads to the production of IL-12 and TNF-α (2) which in turn promotes the 
production of IFN- by NK cells and CD4+ and CD8+ T cells (3). IFN- in turn acts on 
macrophages and activates them (4) to produce NO and other IFN- induced killing mechanisms 
(5) which have toxoplasmacidal effects (6). 
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Toxoplasma normally causes asymptomatic infection in immunocompetent individuals but the 
parasite can cause serious clinical disease in immunocompromised hosts (22, 59). Immunity to T. 
gondii consists of a strong Th1 response that provides protection to the host. However, this 
inflammatory response can become pathological if not appropriately controlled by down-
modulatory cytokines (60, 61). The elucidation of which cells play an important role in 
mediating immunopathology as well as the different roles down-modulatory cytokines play in 
contributing to the resolution of Toxoplasma induced inflammation have been established using 
knock-out mice or antibody depletions. Although CD4
+
 T cells can be extremely beneficial for 
protection in terms of IFN- production, they can also contribute to immunopathology. In a 
mouse model of ocular toxoplasmosis, CD4
+
 T cell responses were observed to mediate the 
ocular inflammatory response to the parasite (62). In another model of infection examining the 
effect of NK cells in immunopathology, CCR5 was established as being necessary for NK cell 
homing into infected tissues. Although NK cells produce IFN- that is known to have anti-
toxoplasmic effects, their lack of recruitment to sites of infection led to a decrease in immune-
mediated tissue injury normally seen in WT counterparts, arguing for their role in 
immunopathology (63). 
 
The host possesses various immunoregulatory and compensatory mechanisms in place that 
prevent or control Toxoplasma induced immunopathology. Studies employing antibody 
depletions or knock-out mice highlight the importance of IL-10, TGF- and IL-27 in the control 
of immune-mediated pathology. IL-10 knock-out mice succumb to infection with Toxoplasma 
fairly quickly with highly elevated serum levels of IL-12, TNF-α and IFN- (60). Similarly, 
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TGF--depleted and orally infected mice develop ileitis as a result of lack of gut homeostasis 
and a rampant ileal inflammatory response that normally would be kept in check by TGF- 
producing intraepithelial lymphocytes (64). The role Il-27 plays in downregulating immune 
responses to Toxoplasma was elucidated using IL-27R knock-out mice. When infected, IL-27R 
KO mice develop lethal inflammatory responses characterized by extensive necrosis in the liver 
and display elevated levels of IFN-, emphasizing the role of IL-27 in the negative control of T 
cell responses during a Toxoplasma infection (65). 
 
Neutrophils 
Discovery, differentiation and granulogenesis 
Neutrophil granulocytes or polymorphonuclear neutrophilic leukocytes (PMN), are one of the 
most effective antimicrobial innate immune cells. There are three types of granulocytes: 
basophils, eosinophils and neutrophils. The neutrophils are the most numerous of all innate 
immune cells. They were originally described over 100 years ago based on their staining 
patterns. When subjected to basic hematoxylin and eosin dyes, basophil cytoplasm stains with 
the basic dye methylene blue, eosinophil cytoplasm is positive for the acid dye eosin red, while 
neutrophils exhibit neutral cytoplasmic staining, thus the name. Neutrophils are the most 
abundant leukocyte in the blood, constituting about 50% to 70% of the circulating white blood 
cells in humans. They have been regarded for years as one of the most important of the induced 
host innate defenders due to the fact that they are the earliest to arrive at sites of infection or 
inflammation. Neutrophils are produced in the bone marrow and exit this site once mature. They 
circulate in the peripheral blood for about 7-10 hours before undergoing apoptosis. 
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Due to their potentially destructive nature, PMN production by the bone marrow is a tightly 
controlled process. Granulopoiesis, or differentiation of granulocytes, occurs in the bone marrow 
over a period of 10 to 14 days and has been divided into stages based on distinctions made on the 
basis of size, nuclear morphology and granule content. The first recognizable entity is the 
myeloblast (MB) which originates from a pool of stem cells. This is followed by differentiation 
into promyelocytes (PM), then myelocytes (MC) followed by metamyelocytes (MM) then band 
cells (BC) leading to a mature PMN (the segmented neutrophil) (refer to figure 1.3A) (66, 67). 
During this differentiation process, neutrophils acquire their characteristic granules that allow 
them to perform many of their functions. Both granulopoiesis and granulogenesis are controlled 
by a number of transcription factors and disruption of this process can lead to deleterious effects, 
such as acute myeloid leukemia (AML) (68). Some of the transcription factors involved in 
differentiation include AML-1, c-myb, C/EBP-α, PU.1, C/EBP-ɛ and CDP (69). 
 
Neutrophil granules are generated in a sequential fashion that follows the differentiation pathway 
described above. Intracellular granules of neutrophils belong to one of the following defined 
categories: azurophil granules (primary granules) which are peroxidase-positive granules, 
specific granules (secondary granules), gelatinase granules (tertiary granules) both belonging to 
the peroxidase-negative granules, and secretory vesicles. All these granules share the common 
characteristics of a phospholipid bilayer membrane and the availability of an intragranular matrix 
stocked with proteins designed for exocytosis or delivery to the phagosome (70). The azurophil 
granules are early-appearing and develop in the MB and PM stages of maturation, while specific 
granules develop after, at the MC and MM stages. Gelatinase granules appear in the BC stage 
while secretory vesicles are the last to be synthesized and appear when the PMN is in its final 
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maturation stage. On the other hand, mature PMN discharge granule or vesicle contents 
following the reverse trend, with the secretory vesicles having the propensity to discharge 
contents first, while the azurophil granules are the last to discharge contents (71, 72). Secretory 
vesicles contain the membrane-associated receptors needed in the first stages of a neutrophil 
immune response, such as the 2-integrin CD11b/CD18, the complement receptor 1 (CR1), 
fMLF receptors (formylmethionyl-leucyl-phenylalanine), CD14 (LPS/lipoteichoic acid receptor) 
and CD16 (FcIII receptor) (73-75). The major components of the gelatinase granules reflect 
their role in neutrophil extravasation and diapedesis while the components of the specific 
granules reflect their role in antimicrobial activities. Both granules share much in common in 
terms of components and these include lactoferrin, hCAP-18, NGAL, histaminases and lysozyme 
(76, 77). They also include three major matrix metalloproteases, MMP-8 (collagenase), MMP-9 
(gelatinase) and MMP-25 (leukolysin) (78-80). Finally, the azurophil granules are usually the 
last to be discharged and contain some of the most dangerous of neutrophil proteins. They are 
stocked with myeloperoxidase (MPO), bacterial permeability increasing protein (BPI), 
cathepsins, defensins, elastase, lysozyme and proteinase (81-83). All of these granules and their 
contents allow neutrophils to efficiently combat various microbial agents (refer to Figure 1.3B-
E). 
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Figure 1.3. Neutrophil granulopoiesis, granulogenesis and granule content. A, 
Granulopoiesis occurs in the bone marrow and starts with myeloblasts (MB) that differentiate 
into promyelocytes (PM), then myelocytes (MC) followed by metamyelocytes (MM) then band 
cells (BC) leading to a mature PMN. B, Azurophil granules develop in the MB and PM stages 
and contain MPO, BPI, and other proteins and are usually last to discharge their contents. C, 
Specific granules develop during the MC and MM stages and contain collagenase, gelatinase and 
various antimicrobial peptides. D, Gelatinase granules develop at the BC stage and contain 
gelatinase, lysozyme and leukolysins. E, Secretory vesicles are the last to develop and contains 
mostly surface proteins and receptors and are usually first to discharge their contents. 
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Neutrophil migration to sites of inflammation 
PMN are usually the first cells to arrive at a site of infection and inflammation and this is usually 
in response to a chemotactic gradient of IL-8 in humans and MCP-2 in mice. Circulating 
neutrophils undergo a step-by-step migration into infection sites which occurs within minutes to 
hours of stimulation and involves a series of regulated exocytic events that are essential for the 
cell’s ability to control infection (70). The process is characterized by slow rolling, adhesion 
strengthening, intraluminal crawling and eventual paracellular and transcellular migration (84). 
The leukocyte adhesion and migration cascade starts with inflamed vascular endothelial cells 
expressing P-selectin on their surface. This serves to interact with P-selectin glycoprotein ligand 
1 (PSGL-1) expressed on neutrophils and allows these cells to start rolling on the endothelium 
(85). Also, endothelial cells express E-selectin and ligands for L-selectin which are present on 
neutrophils (86, 87). The interaction between selectins and their ligands allows for exceptionally 
strong bonds that can withstand the stress induced by blood flow rates. After the capture and 
slow rolling step, the neutrophil will release some of its secretory vesicle contents that allow the 
expression of CD11b/CD18 on the surface of the membrane (88). This expression then allows 
the engagement of ICAM-1 adhesion molecules on the surface of endothelial cells leading to 
firm linkage of neutrophils to the endothelial surface and arrest of rolling. At this step, 
exocytosis of some gelatinase granule components occurs (such as some MMPs) which aid in the 
degradation of the vascular membrane thus facilitating neutrophil extravasation and 
transmigration. At this juncture, the neutrophil has now crossed over to the other side of the 
endothelial cell barrier and will continue its journey to the site of infection or inflammation, 
releasing on its way contents of specific and azurophil granules that further aid in matrix-
degradation and facilitate migration (refer to Figure 1.4A). 
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Neutrophil intracellular killing mechanisms 
Once at the site of infection, neutrophils eliminate invading pathogens through phagocytosis, and 
the resulting microbe-carrying phagosome fuses with lysosomes where the pathogen can be 
killed. Neutrophil killing relies on both oxidative and non-oxidative mechanisms. Oxidative 
mechanisms involve production of reactive oxygen species through the activity of the NADPH 
oxidase enzyme complex, while non-oxidative mechanisms rely on the release of antimicrobial 
peptides and proteases (70, 89). The importance of the NADPH oxidase complex in combating 
diseases and microbial infections is demonstrated in patients with chronic granulomatous disease 
(CGD), who have a defective oxidative burst, and a profound immunodeficiency in combating 
microbial and fungal infections (90-92). The crux of this method of killing is the presence of 
reactive oxygen species (ROS) which are produced as a result of NADPH activity and are 
eventually transferred into the phagocytic vacuole. This transfer of negatively charged molecules 
into the phagocytic vacuole results in a charged imbalance that is compensated by the import of 
K
+
 and other positively charged ions into the vacuole. This positive charge flux then mediates the 
release, solubilization and activation of enzymes, such as proteases, that results in killing (90, 
93). One of the most effective antimicrobial defense mechanisms used by neutrophils is the 
conversion of H2O2 into halide products (particularly chloride) by myeloperoxidase (94). The 
non-oxidative mechanisms of PMN killing involve the deployment of a diverse arsenal of 
proteins and peptides that are stored in granules described earlier and are directed toward 
microbial killing and digestion. Microbicidal proteins usually disrupt anionic surfaces of 
pathogens while proteases will degrade microbial proteins. Together, these killing mechanisms 
were until recently thought to encompass the whole antimicrobial activity of neutrophils (refer to 
Figure 1.4B-E). 
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Neutrophil extracellular traps 
A landmark study by Brinkmann et al. identified a previously unrecognized neutrophil anti-
microbial mechanism involving the release of nuclear DNA that can play a role in extracellular 
killing (95). Neutrophil extracellular traps (NETs) are primarily composed of a DNA backbone 
studded with histones and laced with various anti-microbial peptides that together form an 
extracellular mesh that can trap and kill microbial pathogens (refer to Figure 1.4F) (96). Histones 
present in NETs are H1, H2a, H2b, H3 and H4. The protein components have been shown to 
include bacterial permeability-increasing protein (BPI), myeloperoxidase, cathepsin G, 
lactoferin, gelatinase, peptidoglycan recognition proteins (PGRPs), calprotectin, as well as 
neutrophil elastase (95, 97-101). Release of NETs has been described in neutrophils isolated 
from various species including humans, mice, cows, horses, cats, fish, and even chickens (95, 
102-107). 
 
Since their original discovery in neutrophils, formation of extracellular traps has now been 
described to also occur in eosinophils and mast cells. Key differences in formation and function 
are that traps from eosinophils occur in live cells, happen fairly quickly (in seconds) and are 
mitochondrial in source, while release of extracellular traps from mast cells and neutrophils 
leaves the cells dead, takes longer (minutes to hours), and the DNA is nuclear in origin (108, 
109). 
 
Many molecules have been identified as being responsible in triggering NET formation in 
neutrophils. Some of the most important are: LPS, PMA, GM-CSF/LPS, IL-8, glucose oxidase, 
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Ca
2+
 ionophore, thapsigargin, TNF, and LPS-activated platelets (95, 110-118). In addition to 
molecular triggers, neutrophils have been shown to extrude NETs in response to various 
pathogens and some are susceptible to killing by NETs. These pathogens include Staphylococcus 
aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Shigella flexneri, Salmonella 
typhimurium, Aspergillus fumigatus, Aspergillus nidulans, Leishmania amazonensis, Leishmania 
donovani, Plasmodium falciparum, Escherichia coli, Mycobacterium tuberculosis, Listeria 
monocytogenes and Candida albicans among others (95, 101, 119-127). Of these pathogens, 
some are killed through a combination of histone and anti-microbial peptide activity. Some of 
the pathogens susceptible to NET killing include some of the Streptococcus and Staphylococcus 
species, C. albicans, S. typhimurium, E. coli and A. nidulans. There is also evidence that some 
bacterial pathogens, such as S. pyogenes and S. pneumoniae, avoid killing by NETs by releasing 
nucleases (119, 120). For the case of Leishmania amazonensis, NET entrapment resulted in 
parasite killing partly dependent upon presence of histones (126). Other studies with L. donovani 
promastigotes showed formation of NETs, but in this case parasites evaded killing in dependence 
upon expression of lipophosphoglycan (125). For the case of malaria, there is also evidence for 
Plasmodium falciparum-associated NET formation, and elicitation of anti-nuclear antibodies as a 
result of DNA release may play a role in pathology in infected children (127). To date, it remains 
unclear as to whether viruses induce and/or are trapped and inactivated by extracellular traps. 
 
The process of NET formation has been termed NETosis and is believed to be a pathway of 
programmed cell death that is independent of both apoptosis and necrosis, enabling neutrophils 
to exert anti-microbial activity even after the cells have died. It is now believed that a series of 
nuclear and cytoplasmic events must take place before NETosis. These series of events involve 
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peptidylarginine deiminase (PAD)-mediated histone citrullination, followed by chromatin 
decondensation, nuclear membrane disintegration and the eventual mixing of both nuclear and 
cytoplasmic effector proteins before the ultimate step, which is the extrusion of protein-loaded 
NETs into extracellular space (97, 117, 128, 129). The steps involved in the process of 
extracellular release and how cytoplasmic membrane integrity is breached remains to be 
elucidated and molecular mechanisms underlying this novel type of programmed cell death are 
an active area of investigation (130). NETosis has been shown to depend on the generation of 
reactive oxygen species and a fully functional NADPH complex (131). Neutrophils isolated from 
patients with chronic granulomatous disease (CGD), who have defects in NADPH oxidase 
activity, fail to exhibit NET formation (97, 123). Also, myeloperoxidase and neutrophil elastase 
have been shown to regulate the formation of NETs (132, 133). Recently, Hakkim et al. 
identified a signaling pathway involved in extracellular trap formation that involves a Raf-MEK-
ERK pathway and that inhibition of this pathway led to inhibition of NET formation (134). 
 
The role of NETs in disease has also been an area of concern and intense study and their role in 
both infectious and noninfectious diseases is only now becoming more appreciated. For example, 
during sepsis and upon platelet activation, neutrophils undergoing NETosis can cause endothelial 
injury and ischemia due to the accumulation of proteases (118). Also, the long-held unexplained 
observation that patients with preeclampsia have higher numbers of maternal DNA has now been 
attributed to NETs and their role in entrapping and controlling the release of proinflammatory 
placenta-derived syncytiotrophoblast microparticles (114). In addition, the possible failure of a 
host to completely and sufficiently degrade formed extracellular traps has been postulated as the 
reason behind the development of SLE, usually characterized by the presence of autoantibodies 
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against DNA and histones (135). Taken together, all these studies contribute to the nascent view 
that the release of extracellular traps by neutrophils is an indispensable innate immune defense 
mechanism. 
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Figure 1.4 (previous page). Neutrophil migration to sites of inflammation and killing 
mechanisms. Neutrophils migrate to sites of infection or inflammation following a chemotactic 
gradient. A, Neutrophils circulating in the peripheral blood adhere to the endothelial cells 
through interactions involving selectin molecules and reduce their flow speed to a slow roll. 
After these interactions are strengthened, there is strong adhesion followed by transmigration to 
the tissues. Once at the site of infection, PMN will eliminate pathogens by first phagocytosing 
them (B) which is followed by the formation of a phagolysosome (C). Once the phagolysosome 
is formed, pathogens can be killed by oxidative mechanisms (D) or non-oxidative mechanisms 
(E). F, An extracellular, phagocytosis-independent mechanism for killing involving the 
production of neutrophil extracellular traps (NETs) is another method of PMN killing. These 
NETs are granule-content rich. 
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Neutrophil role in immune modulation 
It is becoming increasingly evident that the classical view of neutrophils as short-lived cells with 
limited ability to affect adaptive immunity is outdated and that their biological significance can 
extend well beyond this view insofar as they display immunoregulatory activities on other cells 
of the immune system (136-141). They are capable of producing many chemokines and 
cytokines that are involved in immune modulation. For example, ample evidence exists showing 
that these cells have prestored pools of cytokines and chemokines such as IL-4, IL-6, IL-12, 
TNF-α and MIP-2 (142-146). Of particular interest is the fact that neutrophils can be stimulated 
to upregulate mRNA expression and release a variety of cytokines and chemokines in addition to 
those they have prestored thus shaping an immune response (detailed below). 
 
Another novel aspect of neutrophils is their ability to closely interact with T cells and even act as 
antigen presenting cells (APC) capable of instructing T cells directly, thus shaping the adaptive 
immune response. There is plenty of evidence in the literature that points to close interactions, 
whether indirect or direct, between PMN and T cells. Various PMN-derived chemokines and 
cytokines that are produced at sites of inflammation have the potential to influence T cell 
activity. For example, chemokines produced by PMN such as CXCL1, CXCL5, CXCL6, 
CXCL7 and CXCL8 are chemotactic for T cell populations. Cytokines such as IL-4 produced by 
neutrophils have effects on Th2 differentiation while IL-12 production has effects on Th1 
differentiation (147). On the other hand, some neutrophil derived products could be T cell 
inhibitory. Arginase, which is present in copious amounts in azurophil granules, when released to 
the extracellular milieu can cause a depletion of L-arginine. This depletion of L-arginine at sites 
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of inflammation has strong effects on T cells and leads to their inhibition since L-arginine is 
essential for T cell activity (refer to Figure 1.5 A-C) (148).  
 
Direct interactions between neutrophils and T cells, and whether PMN can act as antigen 
presenting cells (APC) has been an area of intense investigation. Indeed, evidence for this is 
abundant in humans with chronic inflammatory conditions. Synovial fluid of inflamed joints of 
patients with rheumatoid arthritis contained neutrophils that expressed MHC class II antigens as 
well as CD83 and this expression was dependent on activation by T cells (149). Also, neutrophils 
from patients with Wegener’s granulomatosis expressed MHC class II antigens as well as CD80 
and CD86, whereas neutrophils from patients with inactive disease did not (150). There is 
evidence that neutrophils that have undergone MHC class II upregulation can present 
superantigens (151, 152), and it was shown that mouse neutrophils can stimulate ovalbumin 
(OVA)-specific T cell proliferation, albeit only with pre-processed antigen (153). However, my 
recent work shows unequivocally that PMN can act as APC capable of uptake, processing and 
presentation of OVA antigen to OVA specific T cells. PMN were shown to depend on direct 
contact with T cells to upregulate MHC class II molecules, CD80 and CD83. As a result, they 
were able to present antigen to T cells and skew them towards a Th1 and Th17 phenotype (refer 
to Figure 1.5 D) (154). 
 
As a key component of the innate immune system and the inflammatory response, neutrophils 
make crucial contributions to the recruitment and activation of APC, and especially dendritic 
cells (DC) (136). Neutrophil-derived cytokines and chemokines can help initiate Th1 responses 
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during a Toxoplasma infection by influencing DC function. Toxoplasma triggered neutrophil 
synthesis of CCL3, CCL4, CCL5 and CCL20 and these molecules were highly chemotactic for 
immature DC (155). Also TNF-α production by neutrophils is responsible for the upregulation of 
CD40 and CD86 expression on DC and supernatants from Toxoplasma stimulated PMN can 
induce DC production of IL-12 and TNF-α (156). DC and neutrophils can also interact directly 
with each other through cell-to-cell contact between the DC-specific C-type lectin DC-SIGN and 
the β2-integrin Mac-1, as well as CEACAM1 on neutrophils, and it was also shown that TNF-α 
production by neutrophils is essential for inducing DC maturation, evidenced by upregulation of 
CD83 on these cells (157, 158). These data taken collectively provide a novel cellular link 
between innate and adaptive immunity and enables neutrophils to modulate T cell responses 
through their interactions with dendritic cells (refer to Figure 1.6) (139). 
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Figure 1.5. PMN shaping of T cell responses. A, PMN derived CXCL1, CXCL5, CXCL6, 
CXCL7 and CXCL8 are highly chemotactic for T cells. B, IL-4 and IL-12 cytokines produced by 
neutrophils can have effects on Th1 and Th2 differentiation. C, Arginase contained in PMN 
azurophil granules and released to the extracellular milieu can deplete extracellular L-arginine 
required for T cell activity thus inhibiting it. D, PMN acquire APC characteristics through 
contact with T cells, upregulation MHC class II and costimulatory molecules, thus processing 
and presenting antigen to T cells.  
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Figure 1.6 (previous page). PMN immunomodulatory role through interactions with DC. A, 
Toxoplasma stimulated PMN release of CCL3, CCL4, CCL5, and CCL20 increasing chemotaxis 
of immature DC. B, TNF-α production by PMN after Toxoplasma stimulation leads to 
upregulation of MHC II, CD40 and CD86 on immature DC. C, Supernatants from Toxoplasma 
stimulated PMN induce production of IL-12 and TNF-α by DC. D, Direct contact between 
MAC-1 on PMN and DC-SIGN on DC. E, Direct contact between CEACAM-1 on PMN and 
DC-SIGN on DC.  
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Importance of neutrophils during infection-mouse studies 
The role of neutrophils in microbial infections has been an area of intensive research. Mice 
rendered neutropenic are extremely susceptible to a variety of infectious agents. Mice depleted of 
neutrophils, using the anti-Gr-1 antibody (which recognizes the abundantly expressed neutrophil 
surface marker Ly6C/G), fail to control infections with Aspergillus fumigates, Candida albicans, 
Chlamydia trochomatis, Legionella pneumophilia, Leishmania infantum, Leishmania major, 
Toxoplasma gondii and Listeria monocytogenes among other pathogens (159-173). While the 
effect of neutrophils in some infections is clearly protective and necessary for survival, 
neutrophils can contribute to disease in other infections. Mice depleted of Gr-1
+
 cells and 
infected with Plasmodium berghei ANKA survive longer than mice whose neutrophils were not 
depleted (174). Also, in a mouse model of Cryptococcus neoformans infection, pulmonary 
infection of Gr-1
+ 
depleted mice resulted in better survival rates when compared to non-depleted 
and infected mice (175). 
 
Of interest to our laboratory is the role neutrophils play in the context of a Toxoplasma infection. 
There is evidence that neutrophils are important in a Toxoplasma infection, inasmuch as they are 
rapidly recruited to the site of infection, lack of recruitment in mice lacking CXCR2, the major 
receptor for the neutrophil chemotactic IL-8 like chemokines, correlates with increased 
susceptibility. This CXCR2 deficiency resulted in the establishment of higher cyst numbers in 
the brains of mice when compared to WT controls as well as lower levels of IFN- (176). Our 
laboratory has shown that neutrophils produce a variety of cytokines and chemokines in response 
to a Toxoplasma infection. Of particular importance is the production of IL-12, TNF-α, MIP-1β, 
MIP1-α in human neutrophils, and MyD88-dependent IL-12 and MCP-1 in mouse neutrophils in 
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response to parasite stimulation (49, 177). Also of interest is the fact that during a Toxoplasma 
infection, neutrophils with prestored IL-12 are recruited to the site of infection (142). Our 
laboratory has previously shown that mice depleted of Gr-1
+
 cells and infected with T. gondii 
succumb to the parasite within ten days postinfection with a highly dysregulated Th1 cytokine 
profile. This dependency of Gr-1
+
 cells was shown to be crucial in the early phases of infection, 
since mice depleted of cells starting at 6 days postinfection survive acute infection. This 
depletion also led to uncontrolled tachyzoite replication with exacerbated lesions in multiple 
organs (178). The importance of neutrophils in acute infection and the role these cells play in the 
first days of infection has also been explored by other groups using different pathogens. In 
addition to Toxoplasma, infection models using Mycobacterium tuberculosis, Leishmania 
infantum and Candida albicans have highlighted the importance of neutrophils during early 
stages of infection, since the depletion of neutrophils in the chronic phases of infections had no 
bearing on the outcome of disease (161, 165, 179). 
 
Historically, mice were rendered neutropenic through the administration of the anti-Gr-1 
depleting antibody which recognizes the abundantly expressed Ly6C/G neutrophil surface 
molecule. While this antibody depletes neutrophils very efficiently, it has recently been shown 
that other cells of the immune system can express the Ly6C/G surface molecule. The Gr-1 
surface marker can also be found on a recently described inflammatory monocyte population of 
cells, as well as on plasmacytoid dendritic cells leading to mixed interpretations of anti-Gr-1 
antibody depletions (180-182). However, another characteristic hallmark of neutrophils is their 
surface expression of Ly6G molecules (182). A more recent study makes use of a recently 
available monoclonal antibody that targets the neutrophil-specific Ly6G surface molecule (183). 
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This antibody has not been shown to react with Gr-1
+
 cells and will not deplete non-neutrophil 
specific cell populations. As such, the role of neutrophils in vivo can be assayed by the use of 
Ly6G-specific monoclonal antibody to deplete these cells. Data presented in chapter 4 uses this 
anti-Ly6G monoclonal antibody to evaluate the role of neutrophils in a Toxoplasma infection. 
 
It is becoming increasingly clear that neutrophils are not just scavenging cells but that they can 
also initiate and influence the adaptive immune response during the control of intracellular 
pathogens (137). Although neutrophils make small amounts of cytokines and effector molecules 
on a per-cell basis, their sheer number likely makes them important decision-making 
immunoregulatory cells that are crucial in mounting effective immune responses (136). Taking 
all these data collectively, neutrophils produce a variety of cytokines and chemokines that can 
alter or make various contributions to an immune response. 
 
Brief outline of dissertation research 
Neutrophils have long been regarded as one of the most important cells of the innate immune 
system. The long-held view has been that they are “kamikaze” type cells that migrate to a site of 
inflammation or infection, perform anti-microbial functions, and then die through apoptosis. 
Also, it has long been postulated that their killing mechanisms are mostly intracellular and that 
they lacked any extracellular killing mechanisms or that their role ends at death. PMN ability to 
modulate an immune response well beyond innate immunity has always been an area of 
speculation. 
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This thesis examines newly emerging roles for neutrophils. Chapter 2 shows clear evidence that 
neutrophils can act as professional APC capable of processing and presenting antigen to T cells. 
Neutrophils express T cell contact dependent MHC class II and costimulatory molecules 
necessary for antigen presentation. They also instruct T cells to differentiate into Th1 and Th17 
cells independently of exogenous cytokine addition. Chapter 3 describes neutrophil extracellular 
traps and their role in the control of Toxoplasma. Data presented in Chapter 3 shows that 
Toxoplasma can induce NET formation in both mouse and human neutrophils in an ERK 
pathway dependent fashion. Data presented in this chapter also shows that NET formation by 
neutrophils in response to Toxoplasma can play a role in the control of the tachyzoite. Chapter 4 
addresses the role of neutrophils in a Toxoplasma infection by making use of the neutrophil-
specific anti-Ly6G antibody to deplete mice in vivo. This neutrophil depletion led to a 
dysregulated pulmonary immune response characterized by higher levels of cytokines and 
dysregulated DC function along with overactive T cells. Chapter 5 summarizes the data and 
results from Chapters 2, 3 and 4 and discusses the relevance of these finding and their 
contribution to the advancement of both the neutrophil and Toxoplasma fields as well as 
discusses future directions for each project. 
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Abstract 
Neutrophils play a major role in the innate immune system and are normally considered to be 
short-lived effector cells that exert anti-microbial activity and sometimes immunopathology. 
Here, we show that these cells possess an additional function as professional antigen-presenting 
cells capable of priming a Th1- and Th17-acquired immune response. Using flow cytometry, 
fluorescence microscopy and western blotting, we show that mouse neutrophils express MHC 
class II and co-stimulatory molecules CD80 and CD86 after T-cell co-incubation. Neutrophils 
pulsed with ovalbumin (OVA) process and present peptide antigen to OVA-specific T cells in an 
MHC class II-dependent manner. Importantly, we demonstrate that neutrophils can prime 
antigen-specific Th1 and Th17 immune responses even without the addition of exogenous 
cytokines to cell cultures. 
 
Introduction 
Neutrophils are well known to rapidly and in large number accumulate at sites of infection and 
inflammation. The classical view of these cells is that they function as kamikazi pilots, following 
chemokine gradients to target sites where they kill microbes, simultaneously causing collateral 
tissue damage through discharge of toxic mediators that also result in their own death. 
Subsequent phagocytosis of apoptotic neutrophils is thought to allow their immunologically 
silent removal. Thus, neutrophils are often dismissed as short-term effectors that have no lasting 
impact on the ensuing adaptive immune response to infection (1). 
 
However, there is mounting evidence that polymorphonuclear leukocytes (PMN) may play more 
complex and nuanced roles in immunoregulation. Although the lifespan of neutrophils in the 
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blood is only 8–12 hr, proinflammatory mediators prevent onset of apoptosis, increasing their 
longevity greatly (2). It is also clear that neutrophils produce a large number of cytokines and 
chemokines during infection (3, 4). While on a per cell basis, the amount of any given 
neutrophil-derived cytokine or chemokine is often less than that produced by dendritic cells (DC) 
or macrophages, the sheer number of PMN (they are the most common leukocyte) suggests that 
on a population basis, neutrophils can contribute significantly to the cytokine response during 
infection. There is evidence that neutrophils differentiate into distinct subsets based upon Toll-
like receptor expression and reciprocal secretion of IL-12 and IL-10 (5, 6). The ability of 
neutrophils to produce immunoregulatory cytokines and chemoattractants has led some 
investigators, including us, to propose that these cells play a role in recruitment and activation of 
DC during infection (7, 8). 
 
Another immunoregulatory aspect of neutrophil function comes from evidence that these cells 
may be induced to express MHC class II molecules (9). While PMN from healthy donors do not 
express MHC class II glycoproteins, cytokines such as IFN-γ, granulocyte-monocyte colony-
stimulatory factor (GM-CSF), and IL-3 can stimulate up-regulation (10-12). Interestingly, at 
least two of these mediators (IFN-γ and GM-CSF) also increase neutrophil survival, suggesting 
that prolonged contact between neutrophils and T cells is possible (13-15). It has also been 
reported that neutrophils can express co-stimulatory molecules CD80 and CD86, as well as the 
DC marker CD83. This has led some to propose that PMN are able to transdifferentiate into DC-
like cells under appropriate stimulatory conditions (16-18). There is evidence that human 
neutrophils mediate proliferation of T cells in response to superantigen (11, 19), and it was 
recently shown that mouse neutrophils can stimulate ovalbumin (OVA)-specific T cell 
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proliferation (20). However, whether these responses truly reflect an ability to process and 
present antigen has been less clear. 
 
Here, we show for the first time unequivocal evidence that neutrophils function as bona fide 
professional antigen-presenting cells (APCs), inducibly expressing MHC class II and co-
stimulatory molecules and stimulating MHC class II-dependent proliferation of OVA-specific T 
cells after pulsing with antigenic peptide or intact OVA. Most importantly, we show that antigen-
pulsed neutrophils are potent inducers of Th1 and Th17 differentiation in vitro independent of any 
exogenous cytokine addition. Together, our results demonstrate that neutrophils function as a 
new type of professional APC specializing in driving generation of proinflammatory T cell 
effectors. 
 
Methods and materials 
Mice 
Female C57BL/6 and BALB/c mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME, USA) or Taconic Farms (Germantown, NY, USA) and used at 6–8 weeks of age. MHC 
class II knockout mice on a C57BL/6 background (B6.129-H2-Ab1
tm1Gru
 N12) were purchased 
from Taconic Farms. OT-II transgenic mice expressing an OVA-specific T cell receptor on a 
Rag-1
−/−
C57BL/6 background [C57BL/6-Rag2
tm1Fwa
 Tg(TcraTcrb)425Cbn] were obtained from 
Taconic Farms. All mice were maintained in the Transgenic Mouse Core Facility at the Cornell 
University College of Veterinary Medicine, which is accredited by the American Association for 
Accreditation of Laboratory Animal Care. 
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Percoll gradient purification of neutrophils 
Mice were intraperitoneally (i.p.) injected with 0.5 ml of 10% thioglycollate (Becton Dickinson, 
Franklin Lakes, NJ, USA) and 18–20 hr later, peritoneal exudate cells (PECs) were collected by 
washing the peritoneal cavity with ice-cold PBS (Cellgro, Manassas, VA, USA). After washing 
cells twice with PBS, neutrophils were purified by continuous Percoll gradient centrifugation as 
described elsewhere (21). Briefly, Percoll (GE Healthcare, Fairfield, CA, USA), adjusted to pH 
7.4, was mixed at a ratio of 1: 9 with PEC re-suspended in PBS. The mixture was then 
transferred to a 10 ml polycarbonate centrifuge bottle and ultracentrifugation was performed at 
60 000 × g for 65 min at 4°C using a 50 Ti rotor (Beckman Centrifuges, Brea, CA, USA). The 
layer enriched for neutrophils was collected using a gel-loading pipette tip. Neutrophils were 
subsequently washed twice with PBS and re-suspended in complete DMEM (cDMEM), 
consisting of 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 100 U ml
−1
 penicillin, 
100 μg ml−1 streptomycin, 30 mM HEPES (all purchased from Invitrogen Life Technologies, 
Carlsbad, CA, USA), 10% bovine growth serum (Hyclone, Logan, UT, USA) and 0.05 mM β-
mercaptoethanol in DMEM. Neutrophil preparations were consistently >95% pure, as 
determined by flow cytometry and differential staining. 
 
Bone marrow-derived DC 
Bone marrow derived DC were prepared from flushed femur bone marrow cells. Briefly, bone 
marrow cells were suspended in RPMI (Cellgro, Manassas, VA, USA) supplemented with 10% 
FCS (Hyclone), 100 U ml
−1
 penicillin (Gibco, Carlsbad, CA, USA), 100 μg ml−1 streptomycin 
(Gibco) as well as GM-CSF (20 ng ml
−1
; Peprotech, Rocky Hill, NJ, USA). Cells were fed 3 and 
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6 days after culture initiation with fresh medium and cells were collected on day 9 for use in 
experiments. 
 
Magnetic cell sorting of CD4 T cells 
Splenocyte single-cell suspensions were obtained by gently mashing spleens and passing them 
through a 70-μm filter (BD Falcon, Franklin Lakes, NJ, USA) followed by erythrocyte lysis with 
red blood cell lysis buffer (Sigma-Aldrich, St Louis, MO, USA). Cells were centrifuged at 300 × 
g for 10 min at 4°C. The pellet was re-suspended in MACS buffer (PBS, 0.5% BSA and 2 nM 
EDTA) and MACS anti-CD4 magnetic beads (Miltenyi Biotec, Auburn, CA, USA) were added. 
The sample was mixed and incubated for 15 min at 4°C. Cells were washed using MACS buffer 
and centrifuged at 300 × g for 10 min. The cell pellet was re-suspended in MACS buffer and 
CD4-positive and -negative fractions were separated using an AutoMACS Separator. 
 
Flow cytometry 
Single-cell suspensions were incubated for 30 min at 4°C with FACS buffer (PBS, 1% bovine 
growth serum and 0.01% NaN3) containing 10% normal mouse serum to block Fc receptor 
binding. Samples were centrifuged and pellets were re-suspended in FACS buffer containing 
fluorochrome-conjugated antibody for 30 min at 4°C. The antibodies used in this study were 
anti-Gr-1 FITC (BD Biosciences, San Jose, CA, USA); PE-conjugated anti-Ly6G (BD 
Biosciences), PE-conjugated anti-CD80, PE-conjugated anti-CD86 (BD Biosciences), PE-
conjugated anti-MHC class II and anti-CD4 conjugated to allophycocyanin. Antibodies were 
purchased from eBioscience (San Diego, CA, USA) unless indicated otherwise. After washing, 
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cells were re-suspended in FACS buffer and collected on a BD FACSCalibur flow cytometer. 
Data analysis was performed using FlowJo software (Tree Star, Ashland, OR, USA). 
Intracellular cytokine staining was performed in neutrophil T-cell cultures following a previously 
described protocol (22). At day 3, after initiating cultures of OT-II T cells and OVA peptide-
pulsed neutrophils, cells were pelleted and new medium supplemented with IL-2 (10 ng ml
−1
; 
Peprotech) was added. At day 6, cells were collected, washed and stimulated with phorbol 
myristate acetate (10 ng ml
−1; EMD, Darmstadt, Germany) and ionomycin (1 μg ml−1; 
Calbiochem, Darmstadt, Germany) for 6 hr in the presence of Brefeldin A. Cells were 
subsequently permeabilized and stained for intracellular cytokines and surface stained for 
membrane antigens. 
 
Cell sorting 
In some experiments, high purity neutrophils were obtained by staining thioglycollate-elicited 
cells with PE-conjugated antibody specific for Ly6G (1A8; BD Pharmingen, San Diego, CA, 
USA) for 30 min at 4°C. After extensive washing, cells were re-suspended in PBS with 1% 
bovine growth serum (Hyclone) and sorted based upon expression of Ly6G using a FACSAria 
cell sorter (BD Biosciences). In other experiments, CD4
+
 T cells were isolated by flow 
cytometric sorting after staining cells with anti-CD4 antibody conjugated to allophycocyanin. 
The purity of sorted populations was routinely >98%. 
 
5-(and 6-)Carboxyfluorescein diacetate succinimidyl ester staining of CD4 T cells 
CD4-positive T cells were stained with 5-(and 6-)carboxyfluorescein diacetate succinimidyl ester 
(CFSE) (Molecular Probes, Carlsbad, CA, USA) according to the manufacturer's instructions. 
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Briefly, cells were re-suspended in PBS with 0.1% BSA and CFSE stock solution was used to 
yield a final concentration of 10 μM. Cells were incubated at 37°C for 10 min. The staining was 
quenched by adding five volumes of ice-cold cDMEM followed by incubation on ice for 5 min. 
CFSE-stained cells were further washed for a total of three washes using cDMEM. 
 
Neutrophil and CD4 T cell co-cultures 
Neutrophils, purified by Percoll gradient centrifugation or flow sorting, were either pre-
incubated with medium alone, OVA peptide (amino acids 323–339; AnaSpec, Fremont, CA, 
USA) at a concentration of 2 μg ml−1 or whole OVA antigen (Thermo Scientific, Rockford, IL, 
USA) at a concentration of 20 μg ml−1 for 4 h at 37°C. After extensive washing in cDMEM, 
immunomagnetic bead-purified, or in some cases flow sorted, CFSE-labeled OT-II CD4
+
 T cells 
were added to the neutrophils. After 4 days of culture, cells were collected and surface stained 
for CD4 as described above and CFSE peak dilutions were assayed using flow cytometry. Anti-
MHC class II antibody blocking experiments were performed using Ab M5/114 (eBioscience) at 
a concentration of 5 μg ml−1. Transwell contact inhibition experiments were performed using a 
24-well transwell plate (Costar, Lowell, MA, USA). Neutrophils and T cells were co-incubated 
in direct contact or separated by the transwell membrane with neutrophils in the lower chamber 
and T cells in the upper chamber. After incubation for 2 hr at 37°C, neutrophils were collected 
and stained for MHC class II expression as described above. 
 
Western blotting 
Percoll gradient purified neutrophils, isolated by flow cytometric sorting of Ly6G
high
 cells after 
incubation with T cells, were lysed using SDS sample reducing buffer and stored at -80°C. 
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Samples were subsequently resolved by SDS-PAGE, and immunoblotted using an anti-MHC 
class II Aβ-specific antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) or stripped and 
re-probed for anti-GAPDH-specific antibody (Cell Signaling Technology, Danvers, MA, USA) 
as a loading control. Blots were visualized using an ECL-based detection system (Thermo 
Scientific). 
 
Cytokine ELISA 
IFN-γ in culture supernatants was measured using a commercial kit according to the 
manufacturer's recommendations (eBioscience). IL-17 was measured using a kit from R&D 
systems and IL-4 was measured using a kit from BD Biosciences (BDoptEIA). 
 
Immunofluorescence microscopy 
Neutrophils before or after T cell co-incubation were centrifuged on to glass cover slips for 5 
min at 750 r.p.m. Cover slips were fixed with 3% paraformaldehyde (20 min, room temperature), 
then blocked with normal mouse serum and FCS-supplemented PBS for an hour at room 
temperature. Cover slips were incubated with anti-Gr-1 FITC (BD Biosciences); and PE-
conjugated anti-MHC class II (eBioscience) for an hour at room temperature. After washing in 
PBS, cover slips were mounted with ProLong Antifade containing 4′,6-diamidino-2-
phenylindole (DAPI; Molecular Probes). Images were collected with an Olympus BX51 
fluorescence microscope equipped with a DP 70 camera using Olympus DP controller software 
and Olympus DP manager software. 
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Statistical analyses 
Statistical analyses were performed using the Prism Software. Unpaired t-tests were performed 
to analyze data. P values <0.05 were considered significant. 
 
Results 
Isolation of mouse neutrophils 
To obtain neutrophils, mice were i.p. injected with 10% thioglycollate and PEC were collected 
18-22 hr later. The cell population obtained was routinely 60-80% neutrophils with 
macrophages, mast cells, eosinophils and lymphocytes making up the remaining fraction of cells 
(data not shown). To purify neutrophils, PEC were centrifuged over a Percoll continuous density 
gradient consistently yielding a population of cells that were 96-98% positive for the neutrophil-
associated marker Ly6G (Figure 2.1A). There was routinely <0.5% CD11c
+
, F4/80
+
, and 
CD19
+
cells in this population (Figure 2.1D-F). The Ly6G
+
 population could be divided into 
Ly6G
high
 and Ly6G
interm
 cells (94.7 and 1.7%, respectively; Figure 2.1A). These two populations 
were isolated by flow cytometric sorting of Ly6G
high
 (Figure 2.1B) and Ly6G
interm
 (Figure 2.1C) 
cells. Differential staining of these cells showed that essentially all were neutrophils, as 
determined by their characteristic multilobed nuclei (Figure 2.1B and C, insets). We speculate 
that the Ly6G
interm
 PMN are recent bone marrow emigrants recruited in response to thioglycollate 
injection because it is known that expression of this marker increases with neutrophil maturation 
(23). 
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Expression of MHC and costimulatory molecules on mouse neutrophils 
We previously reported that mouse neutrophils express the molecule CD80 that is associated 
with co-stimulation of T lymphocytes during MHC-restricted antigen presentation (Figure 2.2F, 
inset) and (21). Therefore, we asked whether thioglycollate-elicited PMN also express CD86 and 
MHC class II molecules. We found that freshly isolated cells expressed neither MHC class II 
molecules (Figure 2.2A and B) nor did they express CD86 (Figure 2.2E, gray histogram). 
However, after 2 hr co-incubation with purified CD4
+
 T cells, we detected up-regulation of MHC 
class II molecules (Figure 2.2C and D) as well as increased expression of CD86 (Figure 2.2E) on 
PMN. Levels of CD80 on neutrophils were also slightly up-regulated following T cell co-
incubation (Figure 2.2F). 
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Figure 2.1. Source of neutrophils and absence of APC populations in purified neutrophils. 
(A) Expression of Ly6G by thioglycollate-elicited neutrophils isolated by centrifugation over 
Percoll. The numbers indicate the relative percentage of cells falling within each indicated gate. 
PMN were sorted into Ly6G high (B) and intermediate (C) expressing populations. Insets in 
panels B and C show the morphological appearance of the flow-sorted populations. There was 
minimal cross contamination as determined by staining for DC (CD11c, panel D), macrophages 
(F4/80, panel E) and B cells (CD19, panel F). Data are representative of at least three 
independent experiments. 
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Figure 2.2 (previous page). Co-incubation with T cells induces expression of MHC class II 
and co-stimulatory molecules on neutrophils. (A and C) Expression of MHC class II 
molecules on Ly6C/G (Gr-1)-gated neutrophils without (A) or with (C) 2 hr T cell co-incubation 
(red histograms). Gray shaded histograms show isotype antibody staining. (B and D) Neutrophils 
were imaged by fluorescence microscopy after staining with anti-Ly6C/G antibody (green), anti-
MHC class II antibody (red). Nuclei were stained with DAPI (blue). MHC class II expression on 
neutrophils without (B) and with (D) T cell co-incubation is shown. (E and F) Expression of 
CD86 (E) and CD80 (F) on Ly6C/G-gated neutrophils without T cell co-incubation (shaded 
histogram) relative to expression after T cell co-incubation (red histogram). The insets in panel E 
and F show isotype antibody staining (shaded blue histogram) compared with CD86 and CD80 
expression on neutrophils with T cell co-incubation respectively (red histogram). MHC class II 
and co-stimulatory molecule flow cytometry data are representative of at least four independent 
experiments. The microscopy data are representative of two independent experiments. 
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To further substantiate expression of MHC class II molecules on PMN, we co-incubated 
neutrophils with magnetic bead purified CD4
+
 T cells (Figure 2.3A), then we re-isolated 
neutrophils 2 hr later by cell sorting following labeling with Ly6G-specific antibody (Figure 
2.3B). Neutrophil cell lysates were subjected to western blot analysis using an MHC class II Aβ-
specific antibody. As shown in Figure 2.3(C), neutrophils lysed without pre-incubation with T 
cells (Contr) expressed minimal levels of Aβ chain, consistent with data shown in Figure 2.2(A 
and B). However, supporting the flow cytometry results in Figure 2.2, neutrophil lysates 
prepared after co-incubation with T cells (Post-T) clearly contained increased levels of the MHC 
class II Aβ molecule (Figure 2.3C). This difference in expression is not due to unequal loading of 
samples as shown by blotting against GAPDH (Figure 2.3C). 
 
We sought to determine whether T cell-driven expression of MHC class II on PMN was 
dependent upon release of soluble factors or direct cell-to-cell contact. To answer this question, 
neutrophils and T cells were incubated together or separated by a Transwell membrane. Freshly 
isolated neutrophils incubated alone did not express MHC class II molecules (Figure 2.4A). 
Neutrophils incubated in direct contact with T cells up-regulated expression of MHC class II 
molecules (Figure 2.4B). Strikingly, up-regulation of MHC class II molecules on neutrophils was 
completely abrogated when the cells were separated by a Transwell membrane (Figure 2.4C). 
We conclude that cell contact is required for T lymphocyte-triggered up-regulation of MHC class 
II molecules on PMN. 
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Figure 2.3. Biochemical evidence for MHC class II expression on neutrophils. (A) 
Neutrophils and T cells were co-cultured for 2 hr at 37°C at a ratio of 1:10, then cells were 
labeled with Ly6G-specific antibody. Expression of Ly6G before (A, 10% positive) and after (B, 
98% positive) cell sorting for neutrophils. (C) Western blot showing MHC class IIβ expression 
on neutrophils after T-cell co-incubation (Post-T). C also shows GAPDH loading control blotting 
from the same experiment. Contr, neutrophil lysate prepared without prior T-cell incubation. 
These data were repeated twice with the same result. 
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Figure 2.4. Physical contact between neutrophils and T cells is required for up-regulation 
of MHC class II by neutrophils. (A) Background expression of cell surface MHC class II 
molecules on Ly6C/G-positive neutrophils prior to incubation with T cells. (B) Expression of 
MHC class II molecules on the surface of Ly6C/G-positive neutrophils after 2-hr co-incubation 
with T cells. (C) Expression of MHC class II molecules by neutrophils when the T cells and 
neutrophils are separated by a Transwell membrane. The data are representative of three 
independent experiments. 
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Neutrophils process and present antigen to trigger T-cell activation 
We next tested whether neutrophils expressing MHC class II molecules and co-stimulatory 
molecules were capable of triggering antigen-specific T cell activation. To address this question, 
we used CD4
+
 T lymphocytes from OT-II mice that recognize OVA
323–339
 peptide in the context 
of I-A
d
. Percoll gradient-purified neutrophils were incubated with OVA antigen, washed and 
then added to CFSE-stained OT-II CD4
+
 T cells and the cells were cultured for 4 days. PMN 
survived the 4-day co-culture with T cells, and the relative proportion at day 4 was very similar 
to the input proportion of T cells to neutrophils (Figure 2.5A). In contrast, neutrophils cultured in 
isolation rapidly lost viability (data not shown). Cells were collected, stained for CD4 and 
analyzed using flow cytometry to determine CFSE peak dilutions as an indicator of T cell 
proliferation. As expected, there was minimal proliferation when T cells were cultured with non-
pulsed PMN (Figure 2.5B). In striking contrast, neutrophils pre-incubated with native OVA 
stimulated T cell proliferation (Figure 2.5C). Similarly, pre-incubation of PMN with OVA
323–339
 
peptide also triggered strong T cell proliferation (Figure 2.5D). We asked whether T cell 
proliferation depended upon MHC class II expression, as would be predicted for bona fide 
antigen presentation. As shown in Figure 2.5(E), inclusion of a blocking antibody to MHC class 
II completely abrogated the ability of antigen-pulsed neutrophils to trigger proliferation of OVA-
specific T cells. Notably, that the activation status of isolated CD4
+
 T cells from mice prior to 
incubation with neutrophils was naive, as evidenced by the expression levels of CD44, CD62L 
and CD25 (Figure 2.6A and C) and that these markers change expression upon activation after 
antigen presentation by neutrophils (Figure 2.6B and D). 
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Although Percoll gradient-purified PMN and immunomagnetic bead-isolated CD4
+
 T 
lymphocytes were routinely >95% pure in repeated experiments, we could not completely 
exclude the possibility that residual macrophages or DC in the neutrophil preparations were 
responsible for antigen presentation, or that OVA antigen was acquired by residual APC in the T 
cell preparations. Therefore, to further substantiate antigen presentation by neutrophils, we 
repeated the experiments using high-purity cells generated by flow cytometric cell sorting. The 
purity of Ly6G
+
 neutrophils and CD4
+
 T lymphocytes is shown in Figure 2.5(F and G) and was 
99 and 98% respectively. Pre-incubation of PMN with OVA
323–339
 triggered robust proliferation 
of CFSE-labeled T cells (Figure 2.5H), while co-incubation with non-pulsed neutrophils did not 
induce a T cell response (Figure 2.5I). 
 
We further addressed the possibility that residual APC in the T cell preparation were cross-
presenting OVA antigen by determining the requirement for MHC class II molecules on the 
neutrophil population. As shown in Figure 2.5(J), OVA-pulsed PMN generated from control 
mice stimulated proliferation of CFSE-labeled OVA-specific CD4
+
 T lymphocytes. However, 
when MHC class II-deficient PMN were used, levels of T-cell proliferation were reduced (Figure 
2.5K), with the insets showing purity of the neutrophil populations used as APC. We conclude 
from these results that neutrophils acquire antigen and stimulate T cell proliferation in an MHC 
class II-dependent manner. 
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Figure 2.5 (previous page). Neutrophils process and present antigen to stimulate T cell 
proliferation. (A) Neutrophils were pre-incubated with OVA, then cells were added to OVA-
specific OT-II cells at a PMN to T cell ratio of 1: 10. Four days later, cells were examined under 
the microscope. The arrow points to one of three neutrophils in this image. In panels B-E, the 
ability of Percoll gradient-isolated neutrophils (97% purity) to stimulate immunomagnetic bead-
isolated CD4
+
 T cell (98% purity) proliferation was examined. (B) Non-pulsed neutrophils 
induce low levels of OT-II T cell proliferation in day 4 cultures as measured by CFSE dilution of 
labeled CD4
+
 T cells. (C) Proliferation of OVA-specific OT-II T cells after day 4 co-culture with 
neutrophils pre-incubated (4 hr, 37°C) with whole OVA. (D) OT-II T cells proliferation after 4-
day culture with OVA peptide-pulsed PMN. (E) Addition of anti-MHC class II blocking 
antibody (M5/114) prevents OT-II proliferation stimulated by OVA peptide-pulsed neutrophils. 
Insets in B through E show CFSE peak dilution histograms. Samples in B through E were 
incubated at a ratio of 10 T-cells for every one neutrophil. In panels F-I, the experiments were 
reiterated using flow sorted Ly6G
high
 neutrophils and CD4
+
 OT-II T cells. (F) Neutrophil purity 
after cell sorting (99% Ly6G positive). (G) Purity of OT-II T cells following cell sorting (98% 
CD4 positive). (H) Day 4 proliferation of sorted CFSE-labeled OT-II CD4
+
 T cells after 
incubation with sorted neutrophils pulsed with OVA peptide. (I) Proliferation of sorted OT-II T 
cells after incubation with non-pulsed sorted neutrophils. (J) Proliferation of OVA-specific OT-II 
T cells following incubation with OVA peptide-pulsed neutrophils from MHC class II expressing 
C57BL/6 mice. (K) Proliferation of CD4
+
 T cell following 4-day incubation with OVA peptide-
pulsed neutrophils from MHC class II-deficient mice. Neutrophil purity, based on Ly6G 
expression, is shown in the inserts and was 96.4 and 96.6% in J and K, respectively. Samples in 
(F) through (K) were incubated at a ratio of five T-cells for every one neutrophil. Experiments in 
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(A-D) were performed five times with the same result and the MHC blocking experiment (E) 
was performed three times with the same result. The cell sorting experiment (F-I) was performed 
three times and experiments with MHC class II KO cells were performed two times with the 
same result. 
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Figure 2.6. OTII CD4
+
 T cells exhibit a naive phenotype prior to antigen presentation by 
neutrophils. Expression of CD44 and CD62L by CD4
+
 T cells from a naive spleen of an OT-II 
mouse (A) and expression of these markers after neutrophils antigen presentation in (B). 
Expression of CD25 on CD4
+
 T cells before and after neutrophils antigen presentation is shown 
in (C and D), respectively. The numbers indicate the relative percentage of cells falling within 
each indicated gate. 
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Neutrophils induce differentiation of Th1 and Th17 cells 
Given that OVA-pulsed PMN triggered antigen-specific T cell proliferation, we were interested 
in the type of immune response generated. Therefore, we measured cytokine levels in 
supernatants from PMN and OVA-specific T cell co-cultures and compared these with responses 
in co-cultures of T cells and DC. Surprisingly, even without addition of exogenous cytokines, 
OVA-pulsed, but not control, neutrophils stimulated production of IFN-γ (Figure 2.7A) and IL-
17 (Figure 2.7B). In contrast, parallel cultures of OVA-pulsed DC and T cells displayed minimal 
IFN-γ and no detectable IL-17. Neither PMN nor DC triggered production of IL-4 in T cell co-
cultures (Figure 2.7C). We then examined if cytokine production stimulated by OVA-pulsed 
neutrophils, like the T cell proliferative response, required PMN expression of MHC class II 
molecules. As predicted, IFN-γ (Figure 2.7D) responses were highly dependent upon neutrophil 
MHC class II molecule expression. For the case of IL-17 (Figure 2.7E), there was a major 
reduction in cytokine production using MHC class II-negative neutrophils, but some IL-17 
production clearly remained. The basis for this residual response is not clear. One possibility is 
that neutrophils, which are known to sometimes produce IL-17 (24, 25), release the cytokine in 
response to T cell co-culture. It is also possible that OVA-pulsed PMN produce factors that 
trigger MHC class II-independent T cell IL-17 production. 
 
We also performed intracellular cytokine staining on CD4
+
 T cells following incubation with 
OVA-pulsed neutrophils. As shown in Figure 2.7(F), there was minimal IFN-γ and IL-17 
expression in T cells after co-culture with non-pulsed neutrophils. However, as shown in Figure 
2.7(G), incubation with OVA-pulsed PMN stimulated generation of both Th1 and Th17 T cells as 
defined by production of IFN-γ and IL-17, respectively. Interestingly, we also detected a small 
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population of T cells expressing both of these cytokines. Notably, production of these cytokines 
is largely restricted to CD4
+
 T cells as gating on the CD4
−
 population shows a minimal 
percentage of cytokine being produced (Figure 2.7H), and when plotted as total number of 
cytokine producing cells, it is evident that the cytokines are produced by CD4
+
 T cells (Figure 
2.7I). The cytokines IL-6 and TGF-β together are known to drive Th17 differentiation. Therefore, 
we used blocking mAb to ask whether these cytokines were involved in neutrophil-induced 
generation of Th17 cells. Surprisingly, presence of these antibodies had no effect on the PMN-
induced IL-17 response (Figure 2.8A). In contrast, and as expected, the same antibodies were 
capable of blocking skewing toward IL-17 responses induced by bone marrow-derived DC 
cultured with IL-6 and TGF-β (Figure 2.8B). Thus, antigen-pulsed neutrophils are capable of 
stimulating differentiation of both Th1 and Th17 T cells even without the addition of exogenous 
polarizing cytokines. 
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Figure 2.7 (previous page). OVA-pulsed neutrophils drive differentiation of Th1 and Th17 
cells in vitro. (A-C) PMN and bone marrow-derived DC were pulsed with OVA peptide or 
medium alone (Med) then cultured with OVA-specific T cells. At day 4 after culture initiation, 
supernatants were collected and assayed for IFN-γ (A), IL-17 (B) and IL-4 (C). In (D and E) 
similar cultures were initiated using neutrophils from wild-type and MHC class II knockout 
mice. Day 4 supernatants were tested for IFN-γ (D) and IL-17 (E, where * indicates P<0.001). In 
panels (F and G), the co-cultures were subjected to intracellular cytokine staining following 
incubation with non-pulsed (F) and OVA peptide-pulsed (G) neutrophils. The results in F and G 
show intracellular IFN-γ and IL-17 after gating on CD4+ T cells. Panel (H) shows intracellular 
staining on CD4-negative gated population, while panel (I) shows the total number of cells 
staining positive for IL-17, IFN-γ or both (DP, double positive) in both the CD4 negative and 
positive populations. These experiments were performed twice with the same result. 
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Figure 2.8. Th17 induction by neutrophils is both IL-6 and TGF-β independent. Purified 
neutrophils (A) and bone marrow-derived DC (B) were pulsed with OVA peptide and incubated 
with OVA-specific CD4
+
 T cells for 4 days in the presence of a Th17 skewing cocktail. In the 
indicated samples, an anti-skew mAb cocktail was included. On day 4, cultures were spun down 
and fresh medium supplemented with IL-2 added to co-cultures. Supernatant was collected 3 
days after fresh media addition. Cytokine IL-17 levels were measured by ELISA. M, medium 
only; Skew, IL-17 skewing cocktail consisting of IL-6 (20 ng ml
−1
), TGF-β (1 ng ml−1), anti-
IFN-γ (10 μg ml−1) and anti-IL-12 (10 μg ml−1); αSkew, anti-skewing cocktail consisting of anti-
IL6 and anti- TGF-β mAb each at 10 μg ml−1. 
 
 
 
 
78 
 
Discussion 
Neutrophils are conventionally viewed as short-lived cells that migrate rapidly and in large 
number to sites of infection and inflammation (1). Here, they phagocytose particulate antigen 
and release granule-associated microbicidal mediators, then rapidly undergo apoptotic death. The 
response is completed when tissue macrophages and DC phagocytose apoptotic PMN, thereby 
contributing to resolution of infection and inflammation (26, 27). Yet, it is known that 
neutrophils respond to inflammatory cytokines by producing immunoregulatory mediators and 
delaying their own apoptotic death, suggesting a more active role for PMN during infection (28-
30). The results of the present study unequivocally demonstrate that neutrophils express MHC 
class II molecules that directly present antigenic peptide, induce T cell proliferation and promote 
generation of Th17 effector cells. MHC class II molecules were not constitutively expressed by 
neutrophils, but instead up-regulation of these proteins required contact with T cells. Therefore, 
the present results reinforce an emerging view of PMN as active orchestrators of innate and 
adaptive immunity (1). 
 
Our data show that OVA-pulsed neutrophils are programmed to induce Th17 differentiation even 
without addition of exogenous cytokines. This would appear to be an important, and possibly 
unique, property of PMN. Other APC, such as DC, typically require addition of recombinant 
cytokines to mediate optimal T-lymphocyte subset differentiation during cell culture. Th17 cells 
are now understood to be an independent T-cell lineage whose differentiation is controlled by 
TGF-β and IL-6 (31-33). Th17 cells are implicated in autoimmunity and inflammation associated 
with several diseases, including Crohn's disease in humans and experimental autoimmune 
encephalitis in mice (31). The cells are also important in host defense, insofar as they have been 
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shown to play a protective role during infection with extracellular pathogens such as Klebsiella 
pneumoniae, Staphylococcus aureus and Candida albicans (34-36). 
 
A key property of IL-17, the signature cytokine of Th17 cells, is its ability to promote neutrophil 
recruitment and granulopoiesis. This is mediated by chemokines such as macrophage 
inflammatory protein-2 and growth factors such as granulocyte colony-stimulating factor and 
stem cell factor (36). IL-17 is also known to potentiate neutrophil cytotoxic and phagocytic 
activity (37, 38). Our results reveal an amplification loop in which antigen-loaded PMN induce 
Th17 generation; production of IL-17, in turn, can be expected to promote increased neutrophil 
activity. Further evidence for cross talk between neutrophils and Th17 cells is provided by data 
showing mutual chemoattraction between these cell types mediated by reciprocal expression of 
chemokines and chemokine receptors (39). 
 
While neutrophils can produce IL-12 that drives Th1 generation (3, 4), the neutrophil factors 
responsible for Th17 induction are not yet known. In this regard, it has been reported that 
apoptotic PMN favor Th17 generation. This is mediated through IL-6 and TGF-β elaboration by 
APC phagocytosing apoptotic neutrophils (40). Whether a similar pathway is involved in 
neutrophil-dependent Th17 generation described here is not known. However, we found that 
blocking antibodies specific for IL-6 and TGF-β failed to affect Th17 generation driven by OVA-
pulsed PMN, arguing that these cytokines are not involved in neutrophil driven Th17 induction. 
We are currently pursuing the possibility that presently undefined neutrophil mediators induce 
differentiation of this T cell subset independently of TGF-β or IL-6. 
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Neutrophils are not generally known for their ability to serve as professional APC. Nevertheless, 
some studies provide evidence that PMN can be induced to express MHC class II and co-
stimulatory molecules. For example, both precursor and mature human PMN up-regulate MHC 
class II molecules following stimulation with either GM-CSF, IFN-γ or IL-3 (10, 12, 41). It has 
also been reported that cross-linking of neutrophil CD11b results in up-regulation of MHC class 
II molecules on PMN (42, 43). Unlike several cytokines secreted by neutrophils (44-46), 
expression of MHC class II molecules results, at least in part, from up-regulation of mRNA 
synthesis, rather than exocytosis of preformed MHC class II protein from intracellular granules 
(11). Neutrophil MHC class II expression has also been reported at the site of inflammation in 
rheumatoid arthritis, in Wegener's granulomatosis and in persistent Staphylococcus aureus 
infection (17, 47, 48). Similar to MHC class II molecules, the co-stimulatory molecules CD80 
and CD86 have been shown to be up-regulated on neutrophils in response to inflammatory 
cytokines and during autoimmune pathology (16, 17, 42). 
 
Despite this evidence, the functional consequences of inducible MHC class II and co-stimulatory 
CD80/CD86 on neutrophils has been unclear. Using human PMN, it has been shown that these 
cells stimulate T cell proliferation in response to the superantigens Staphyloccocal enterotoxin A 
and E (11, 19). In related experiments, neutrophils have been found to process exogenous 
bacterial antigens for MHC class I-restricted presentation to CD8
+
 T lymphocytes (49). These 
cells could also secrete processed peptide that was subsequently acquired by neighboring 
macrophages or DC. More directly related to our studies, it was recently shown that mouse 
neutrophils loaded with antigenic OVA peptide stimulated proliferation and cytokine secretion 
by antigen-specific CD4
+
 T cells (20). Our results are significant insofar as they are the first to 
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demonstrate a neutrophil capability to actively process and present peptide antigen to T cells and 
to simultaneously trigger Th17 differentiation. 
 
In addition to their effects on T cells, there is clear evidence that PMN exert immunoregulatory 
effects on DC (8). Neutrophils release chemokines that attract both DC and T cells and they 
release cytokines that trigger DC co-stimulatory molecule expression as well as IL-12 and TNF-
α secretion (50-53). This is mediated through physical contact mediated by LewisX carbohydrate 
moeities on PMN Mac-1 and DC-SIGN expressed by DC, combined with neutrophil release of 
TNF-α (54). Neutrophils also release several mediators during degranulation or apoptosis, and 
many of these serve as ‘alarmins’ that mobilize and activate APC (55). Among the alarmins 
produced by neutrophils are the human α-defensins HNP-1 and HNP-2 that chemoattract 
immature DC and naive T cells (53). Notably, these peptides function as adjuvants when 
administered to mice with OVA (56). Thus, neutrophils possess the ability to activate DC as well 
as directly trigger antigen-specific T cell immunity during infection. 
 
The concept that a single APC can present antigen to T cells and provide polarizing signals that 
drive T-cell subset differentiation has received considerable attention. DC are well known to 
serve this role during Th1 induction. Recently, it was proposed that IL-4-producing basophils can 
function similarly in presenting antigen and stimulating Th2 differentiation (57-59). Our results 
suggest that neutrophils are a third type of APC that possesses a parallel ability to directly 
stimulate naive T cells and instruct differentiation to the Th1 and Th17 effector T cell subsets, a 
finding with broad implications with regard to disease pathogenesis and control of infection. 
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Abstract 
Neutrophils have recently been shown to release DNA-based extracellular traps that contribute to 
microbicidal killing and have also been implicated in autoimmunity. The role of neutrophil 
extracellular trap (NET) formation in the host response to nonbacterial pathogens has received 
little attention and remains largely unexplored. Here, we show for the first time that the 
protozoan pathogen Toxoplasma gondii elicits production of NETs from human and mouse 
neutrophils. Tachyzoites of each of the three major parasite strain types were efficiently 
entrapped within NETs, resulting in decreased parasite viability. We also show that Toxoplasma 
activates a MEK-ERK pathway in neutrophils and that inhibition of this pathway leads to 
decreased NET formation. To determine if Toxoplasma induced NET formation in vivo we 
employed a mouse intranasal infection model. We found that administration of tachyzoites by 
this route induced rapid tissue recruitment of neutrophils with evidence of extracellular DNA 
release.  Taken together, these data indicate a role for NETs in the host innate response to 
protozoan infection. We propose that NET formation limits infection by direct microbicidal 
effects on Toxoplasma as well as by interfering with the ability of the parasite to invade target 
host cells. 
 
Introduction 
Neutrophils have long been regarded as one of the most important of the induced host innate 
defenders primarily because they are the earliest cells to arrive at sites of infection or 
inflammation in response to chemotactic signals. They can rapidly accumulate in large numbers 
and deploy a diverse arsenal of weapons aimed at eliminating invading pathogens. Resolution of 
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inflammation and infection involves apoptosis of neutrophils and phagocytic elimination by 
macrophages. As such, neutrophils are often regarded as potent but short-lived cells with limited 
ability to affect adaptive immunity (1). Nonetheless, their biological significance may extend 
beyond this view insofar as neutrophils can also display immunoregulatory activity on other cells 
of the immune system (1-6). 
 
Neutrophils engulf pathogens through phagocytosis, and the resulting microbe-carrying 
phagosome fuses with lysosomes where the microorganism can be degraded. Microbial killing 
relies on both oxidative and non-oxidative mechanisms. Oxidative mechanisms involve 
production of reactive oxygen species through the activity of the NADPH oxidase enzyme 
complex, while non-oxidative mechanisms rely on the release of antimicrobial peptides and 
proteases (7, 8). Together, these mechanisms were until recently thought to encompass the whole 
antimicrobial activity of neutrophils.   
 
A landmark study by Brinkmann et al. identified a previously unrecognized neutrophil anti-
microbial mechanism involving release of nuclear DNA that can entrap and kill extracellular 
pathogens (9). Originally discovered in neutrophils, formation of extracellular traps has now 
been described in eosinophils and mast cells (10, 11). Neutrophil extracellular traps (NETs) have 
been shown to be composed of a DNA backbone studded with histones and laced with various 
anti-microbial peptides that together can kill microbial pathogens. Several bacterial and fungal 
pathogens have been shown to be susceptible to NET killing, including Staphylococcus aureus, 
Streptococcus pyogenes, Streptococcus pneumoniae, Escherichia coli, Mycobacterium 
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tuberculosis, Listeria monocytogenes and Candida albicans (9, 12-16). There is also evidence 
that some bacterial pathogens avoid killing by NETs by releasing nucleases (12, 13). At present, 
much less is known about the extent to which neutrophils form NETs in response to protozoan 
pathogens, although there is recent evidence for Leishmania-induced NET formation (17, 18). 
 
The ability of another major protozoan parasite, Toxoplasma gondii, to elicit neutrophil 
recruitment during infection raises the question of whether or not NET formation is elicited by 
this important human opportunistic pathogen. Toxoplasma normally causes asymptomatic 
infection in immunocompetent individuals but the parasite can cause serious clinical disease in 
immunocompromised hosts (19, 20). Immunity to T. gondii consists of a strong Th1 response that 
provides protection to the host. However, this inflammatory response can become pathological if 
not appropriately controlled by down-modulatory cytokines (21, 22). There is evidence that 
neutrophils play a role during Toxoplasma infection, inasmuch as they are rapidly recruited to 
the site of infection, lack of recruitment in the absence of CXCR2 correlates with increased 
susceptibility, and they are capable of producing several cytokines and chemokines in response 
to the parasite (23-26). The ability of Toxoplasma to elicit formation of NETs has not been 
addressed. 
 
Here, we show for the first time that both murine and human neutrophils release NETs in 
response to all three major clonal lineages of Toxoplasma, and that the parasites become 
physically entrapped by these macromolecular structures. Formation of NETs (also called 
NETosis) is invasion independent, but partially depends upon activation of ERK1/2 MAPK. In a 
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mouse intranasal infection model that stimulates rapid neutrophil accumulation into the lungs, 
we provide in vivo evidence for release of NETs in response to the parasite. We hypothesize that 
NET release by neutrophils functions as an innate mechanism of parasite killing, and that by 
trapping parasites, NETs interfere with the ability to infect host cells and establish infection.  
 
Materials and Methods 
Mice 
Female C57BL/6 and Swiss Webster mice were purchased from The Jackson Laboratory (Bar 
Harbor, ME, USA) or Taconic Farms (Germantown, NY, USA) and used at 6-8 wk of age. 
C57BL/6 LYS-eGFP knock-in mice were a generous gift from David Sacks (National Institutes 
of Health). All mice were maintained in the Transgenic Mouse Core Facility at the Cornell 
University College of Veterinary Medicine, which is accredited by the American Association for 
Accreditation of Laboratory Animal Care. All animal experiments were approved by the Cornell 
University Institutional Animal Care and Use Committee. 
 
Mouse neutrophil isolation 
Mouse neutrophils were isolated as previously described (27). Briefly, mice were i. p. injected 
with 0.5 ml of 10% thioglycollate (Becton Dickinson, Franklin Lakes, NJ, USA) and 20 hr later, 
peritoneal exudate cells (PEC) were collected by peritoneal cavity lavage with PBS (Cellgro, 
Manassas, VA, USA). Neutrophils were subsequently purified by continuous Percoll gradient 
centrifugation as described elsewhere (28). Briefly, Percoll (GE Healthcare, Fairfield, CA, 
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USA), adjusted to pH 7.4, was mixed at a ratio of 1:9 with PEC resuspended in PBS. The 
mixture was then transferred to a 10 ml polycarbonate centrifuge tube and ultracentrifugation 
was performed at 60,000 x g for 65 min at 4°C using a 50 Ti rotor (Beckman Centrifuges, Brea, 
CA, USA). The layer enriched for neutrophils was washed twice with PBS and resuspended in 
complete DMEM (cDMEM), consisting of 1 mM sodium pyruvate, 0.1 mM nonessential amino 
acids, 100 U ml
-1
 penicillin, 100 µg ml
-1
 streptomycin, 30 mM HEPES (all purchased from 
Invitrogen Life Technologies, Carlsbad, CA, USA), 2% bovine growth serum (Hyclone, Logan, 
UT, USA), and 0.05 mM -mercaptoethanol in DMEM. Neutrophil preparations were routinely 
over 95% pure. 
 
Human neutrophils 
Human neutrophils were purified as described previously (29). Briefly, human peripheral blood 
was collected from healthy adult donors following informed consent.  Neutrophils were isolated 
by centrifugation at 500 x g for 50 min at 23°C in a Sorvall ST 16 Centrifuge (Fisher Scientific, 
Pittsburgh, Pennsylvania) using 1-Step Polymorphs (Accurate Chemical and Scientific 
Corporation, Westbury, NY, USA.) The neutrophil layer was collected and washed twice in Ca
2+
 
and Mg
2+
 free HBSS and any remaining red blood cells were subjected to hypotonic lysis by 
brief incubation in DPBS: endotoxin-free water (ratio of 1:6) followed by osmotic restabilization 
with 4 x DPBS. The cells were resuspended in HBSS containing 0.5% HSA, 2mM Ca
2+
, 10 mM 
HEPES, buffered to pH 7.4. 
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HL60 differentiation 
HL60 differentiation was performed as described earlier (30). Briefly, HL-60 cells (4 x 10
5
 cells 
ml
-1
) were treated with 1.25% dimethylsulfoxide (DMSO, Calbiochem) in RPMI 1640 
supplemented with 5% heat-inactivated FBS for 4 days.  Differentiated cells were harvested by 
centrifugation at 500 x g for 10 min at room temperature, and washed once with medium used in 
NET experiments. 
 
Picogreen DNA measurement 
Extracellular DNA was quantitated using a previously described method (31). Briefly, 2 x 10
5
 
neutrophils were seeded in triplicate into a 96-well cell culture plate (Costar, Corning, NY, 
USA). Medium, PMA or parasites were added to the cells and the plate was briefly centrifuged 
to synchronize infection. At the indicated time points, 50 l of 500 mU ml-1 micrococcal 
nuclease (Worthington Biochemical, Lakewood, NJ, USA) was added and the culture was 
incubated for 10 min at 37°C. Enzymatic digestion was terminated using 5 mM EDTA and 
cultures were centrifuged at 200 x g for 8 minutes. 100 l of the cell free supernatant was 
transferred to a flat bottom 96-well plate for quantification of double-stranded DNA using the 
Quant-iT Picogreen assay (Invitrogen, Carlsbad, CA, USA). 100 l of Picogreen reagent was 
added to the samples which were then incubated at room temperature in the dark for 4 min. 
Extracellular DNA was measured in a spectrofluorometer at 480 nm excitation and 520 nm 
emission. 
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Sytox Green viability assay 
Mouse neutrophils with parasites tagged with Tomato Red protein (generated by Dr. B. Striepen, 
University of Georgia and kindly provided by Dr. E. Robey, University of California-Berkeley) 
in the presence of 1 M cytochalasin D (Calbiochem, Darmstadt, Germany) to inhibit parasite 
invasion. After 4 hr at 37°C, media was aspirated and coverslips incubated with Sytox Green live 
cell exclusion dye (Invitrogen, Carlsbad, CA, USA) for 10 min at room temperature. Coverslips 
were then rinsed in PBS, mounted using ProLong Antifade containing 4′,5-diamidino-2-
phenylindoleI (Molecular Probes, Carlsbad, CA, USA) and visualized by fluorescence 
microscopy. 
 
ERK1/2 inhibition 
To inhibit ERK phosphorylation, cells were pretreated with 10 µM of the MEK 1/2 inhibitor 
U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene; Cell Signaling 
Technology, Danvers, MA, USA) for 2 hr at 37°C. Parasites (MOI 5:1) or PMA (60 nM) were 
then added to the cells and samples were subsequently collected for fluorescence microscopy or 
were lysed with SDS sample reducing buffer for Western blot analysis. 
 
Western blotting 
Cell lysates were resolved by SDS-PAGE, and immunoblotted using an anti-phospho-p44/42 
MAPK (ERK1/2) and anti-phospho-p38 Ab (Cell Signaling Technology, Danvers, MA, USA). 
Blots were stripped and re-probed for total p44/42 ERK and p38 antibodies (Cell Signaling). 
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Blots were visualized using an ECL-based detection system (Thermo Scientific, Rockford, IL, 
USA). 
 
Immunofluorescence microscopy 
Neutrophils were incubated on poly-L-lysine treated glass coverslips in a 24-well plate with 
medium, PMA or Toxoplasma, centrifuged for 5 min at 200 x g to initiate infections, followed by 
incubation at 37°C for the indicated times. Samples were collected by gently removing 
coverslips, fixing with 3% paraformaldehyde (20 min, room temperature), then blocked in PBS 
supplemented with normal mouse serum and fetal calf serum for 1 hr at room temperature. 
Coverslips were incubated with FITC-conjugated anti-Toxoplasma SAG-1 Ab (Argene, 
Massapequa, NY, USA), then washed and mounted with ProLong Antifade containing 4′,5-
diamidino-2-phenylindoleI (Molecular Probes). Staining with anti-histone H3 Ab was 
accomplished according to the manufacturer’s instructions (Cell Signaling Technology). Briefly, 
coverslips were fixed as described above, then permeabilizated using ice-cold 100% methanol 
for 10 min at -20°C followed by washing in PBS. Coverslips were blocked for one hr at room 
temperature then incubated overnight with anti-histone H3 Ab. Coverslips were then washed 
three times with PBS and incubated with Alexa Fluor-647 goat-anti-rabbit IgG (H+L) Ab 
(Invitrogen, Carlsbad, CA, USA) for 2 hr at room temperature. After rinsing in PBS, coverslips 
were mounted with ProLong Antifade containing DAPI. Images were collected with an Olympus 
BX51 fluorescence microscope equipped with a DP 70 camera using Olympus DP controller 
software and Olympus DP manager software or an SP5 Leica confocal microscope. 
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Mouse intranasal infection model 
5 x 10
7
 RH strain parasites in PBS were administered in a total volume of 50 µl intranasally to 
Swiss Webster mice. Control mice were intranasally administered the same volume of sterile 
PBS. Mice were euthanized 6 hr post-infection and lungs were perfused with 3% 
paraformaldehyde through tracheal injection. Lungs were then excised and further fixed by 
immersion in 3% paraformaldehyde overnight. Lungs were then paraffin embedded and 
sectioned for staining. Bronchoalveolar lavage fluid (BALF) was collected by washing lungs 
with 200 µl of PBS twice. Samples were spun down at 1000 r.p.m for 8 minutes and supernatants 
assessed for dsDNA content using the Picogreen assay described above. 
 
Statistical analyses 
Statistical analyses were performed using the Prism Software. Two way ANOVA unpaired tests 
with Turkey’s post test analysis and One way ANOVA tests with Bonferroni post test analysis 
were used to determine statistical significance. P values<0.05 were considered significant.  
 
Results 
Mouse neutrophils undergo NETosis in response to PMA 
Most studies to date that examine NET formation have employed human neutrophils (9, 17, 32, 
33). We wanted to determine whether mouse PMN could also release NETs after appropriate 
stimulation, and in particular in response to T. gondii. We used as a cell source thioglycollate-
elicited, Percoll gradient-purified mouse neutrophils (27). In addition, we employed cells isolated 
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from LYS-eGFP knock-in mice in which GFP-tagged lysozyme is constitutively expressed. The 
reasoning for this was that it has been shown that lysozyme is retained inside cells undergoing 
NETosis (34). Since NETs are composed of a DNA backbone with histone molecules studded 
across the DNA fibers, we stained for both DNA and histones as a positive identifier of NET 
formation. As shown in Figure 3.1A, neutrophils incubated in medium alone did not 
spontaneously extrude extracellular traps, as determined by absence of staining for extracellular 
DNA and histone H3. However, we show in Figure 3.1B that neutrophils incubated with PMA 
for 4 hrs formed extracellular traps, as determined by release of DAPI-positive strand-like 
material (panel a) that also stained positive for histone H3 (panel b). Further confirmation for 
NETosis was that, as predicted, there was no concurrent release of intracellular lysozyme (c). To 
quantify NET formation over time, cells were stimulated with PMA then they were treated at 
specific time points with micrococcal nuclease to solubilize extracellular DNA. Cell-free 
supernatants were tested for nucleic acid content using PicoGreen, a fluorochrome that binds 
specifically to double-stranded DNA. As is shown in Figure 3.2A, PMA induced robust release 
of DNA, which could be detected within 2 hr of PMN stimulation.  
 
Toxoplasma elicits NET formation by mouse neutrophils 
To determine whether Toxoplasma triggers release of extracellular traps from mouse neutrophils, 
we incubated thioglycollate-elicited PMNs with tachyzoites and determined NET formation 4 hr 
later. As shown in Figure 3.3A-D, co-incubation with the Type I lineage RH strain stimulated 
formation of NETs, as determined by DNA release (panel A) and staining for histone H3 (panel 
B). Furthermore, staining for Toxoplasma (panel C and D) showed evidence for parasite 
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entrapment within the NETs. As with neutrophil stimulation with PMA (Figure 3.2A), rapid 
release of double-stranded DNA during co-incubation with tachyzoites could also be 
quantitatively measured by PicoGreen binding (Figure 3.2B). There are 3 major clonal lineages 
of T. gondii that differ in host responses elicited (35, 36), prompting us to ask whether they differ 
in ability to induce NETs. However, we found that like the Type I RH strain (Figure 3.3A-D), 
both Type II (Figure 3.3E and F) and Type III (Figure 3.3G and H) parasite strains triggered 
release of NETs in which parasites appeared to be entrapped. 
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Figure 3.1. Thioglycollate-elicited mouse neutrophils produce NETs in response to PMA. 
Purified PMN from Lys-eGFP mice were incubated for 4 hr in medium alone (A) or medium 
with 600 µM PMA (B). NETs were visualized by staining with DAPI (a) and histone H3 (b). 
Lysozyme was retained within cells confirming that NET formation was a regulated event rather 
than non-specific cell lysis (c). Merged images are shown in d. The scale bar indicates 20 µm. 
These experiments were repeated at least 3 independent times with similar results. 
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Figure 3.2. Quantitative measurement of PMA and Toxoplasma-induced NET formation. 
Mouse neutrophils were either stimulated with 600 M PMA (A) or infected with RH strain 
tachyzoites (MOI 5:1) and NET formation was measured by solubilizing extracellular DNA and 
measuring PicoGreen fluorescence in supernatants as an indicator of double-stranded DNA. Data 
for both experiments have been corrected to account for contribution to the fluorescence signal 
by either cells incubated with medium alone or parasites incubated with medium alone. 
Experiments were repeated at least 3 independent times with similar results. * p< 0.05, ** p< 
0.01 relative to time-point zero. 
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Figure 3.3. Release of NETs occurs in a parasite strain-independent manner. Purified mouse 
neutrophils were added to Type I (RH; A-D), II (PTG, E and F) and III (CTG; G and H) strains 
of Toxoplasma and NET formation was assessed 4 hr later by staining for DNA (A, F and H) and 
histone H3 (B). Tachyzoites were visualized by staining with Ab to parasite surface protein 
SAG-1 (C, E, and G). The insets in panels D, F, and H are merged and expanded images 
showing entrapment of parasites within NETs. The scale bars indicate 20 µm. Experiments were 
repeated at least 3 independent times with similar results. 
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Active invasion is not required for NET formation  
We envisioned that Toxoplasma could stimulate NET release during invasion of host cells, or 
that neutrophil DNA release could be triggered by soluble factors derived from extracellular 
parasites. To distinguish between these possibilities, we asked whether NET formation occurred 
in the presence of cytochalasin D, a drug blocking actin polymerization that is required for 
parasite entry into the host cell (37). Figure 3.4A shows formation of NETs when co-incubation 
with parasites (shown in Figure 3.4B) is carried out in the presence of cytochalasin D. The 
merged image shown in Figure 3.4C also reveals clear evidence of parasite entrapment within 
NETs (Figure 3.4C). We conclude that invasion of host neutrophils is not required for NET 
induction by T. gondii. 
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Figure 3.4. NET formation in murine neutrophils does not require invasion. Neutrophils 
were incubated with Toxoplasma (RH strain, MOI 5: 1)) for 4 hrs in the presence of cytochalasin 
D (1 M). A, DAPI staining of DNA reveals presence of NETs. B, the same image showing 
parasite SAG-1 staining. The merged image in C, and the expanded area within the red box 
reveals SAG-1-positive material entrapped within a NET. The scale bar in C represents 10 µm. 
This experiment was performed on three independent occasions. 
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Killing of T. gondii in NETs 
We next assessed the viability of parasites entrapped within NETs, since these structures are 
known to contain anti-microbial components. To address this issue, we made use of Sytox 
Green, a live-cell exclusion dye that binds to dsDNA within dead cells or parasites, and that 
would also be expected to bind NETs. These experiments also employed a transgenically 
modified RH parasite strain that constitutively expresses Red Tomato fluorescent dye. In the 
presence of cytochalasin D neutrophils generated NETs (Figure 3.5A) during co-incubation with 
fluorescent tachyzoites (Figure 3.5B). Staining with Sytox Green revealed that many tachyzoites 
were nonviable (Figure 3.5C and D). In this experiment, less than 1% of tachyzoites stained with 
this live-cell exclusion dye in the absence of neutrophils, but after co-incubation approximately 
25% of parasites were Sytox Green positive (Figure 3.5I). To determine whether parasite death 
was dependent upon NET formation as opposed to some other mechanism of killing, parallel 
experiments were performed in the presence of DNase. As expected, inclusion of this nuclease 
prevented formation of NETs (Figure 3.5E and G). Strikingly, tachyzoites that were present in 
these cultures (Figure 3.5F) failed to take up Sytox Green (Figure 3.5G and H). In this 
experiment, less than 1% of parasites took up this dye when DNase was included to prevent NET 
formation (Figure 3.5I). We conclude that NETs promote extracellular killing of parasites.  
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Figure 3.5 (previous page). Parasites are killed in the presence of NETs. In panels A-D, 
neutrophils were incubated with transgenic RH strain parasites expressing Tomato Red 
fluorescent protein in the presence of cytochalasin D, and 4 hr later cells were stained with the 
live-cell exclusion DNA dye Sytox Green. A, DAPI stain; B, Red fluorescence associated with 
parasites; C, Sytox Green staining. Panel D and the enlarged field show the merged image. 
Yellow arrows indicate parasites whose nuclei stain with Sytox Green (nonviable) and red 
arrows indicate tachyzoites that exclude the dye (viable). In parallel (panels E-H), the experiment 
was carried out in the presence of DNase (1 µg ml
-1
). Under this condition, NETs failed to form 
(E and G) and parasites (F) excluded Sytox Green (G and H). Panel I shows quantitation of 
Sytox Green positive parasites incubated alone (TZ), in the presence of neutrophils (PMN/TZ) 
and in the presence of neutrophils with DNase (PMN/TZ/DNase). * p<0.05. This experiment was 
performed on three independent occasions. 
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Human neutrophils release NETs in response to Toxoplasma gondii 
Next, we sought to determine whether human neutrophils also responded to Toxoplasma with the 
formation of extracellular traps. To address this question, we first assessed extracellular release 
of nuclear DNA employing the human promyelocytic leukemia cell line HL-60 that can be 
induced to differentiate into mature, neutrophil-like myeloid cells when treated with 
dimethylsulfoxide (30). We determined whether differentiated HL-60 cells responded to 
parasites by extruding DNA using the PicoGreen DNA assay. As shown in Figure 3.6A, Type II 
PTG parasites stimulated release of extracellular DNA with kinetics similar to that seen using 
mouse PMN (Figure 3.2A). Examination of the cells revealed presence of Sytox Green-positive 
DNA strands similar to that with stimulated mouse neutrophils (Figure 3.6B).  
 
We then sought to determine whether or not freshly isolated human peripheral blood neutrophils 
also released NETs upon parasite stimulation. Human neutrophils activated with PMA 
underwent a robust, time-dependent release of extracellular DNA as measured by PicoGreen 
staining (Figure 3.7A). Cells infected with Toxoplasma also underwent similar release of 
extracellular DNA, and as predicted from the behavior of mouse neutrophils, blocking invasion 
with cytochalasin D had no effect on DNA release (Figure 3.7A). NET release by human 
neutrophils was confirmed visually by immunofluorescence assay (Figure 3.7B-E). Cells were 
incubated with T. gondii in the presence of cytochalasin D for 4 hr then fixed and stained for 
parasites and DNA. Figure 3.7B and C dramatically shows an extensive network of extracellular 
traps formed in response to Toxoplasma. In the merged image (panel D), evidence for 
entrapment of parasites is clearly visible. 
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Figure 3.6. Differentiated HL-60 cells form extracellular traps in response to Toxoplasma. 
HL-60 cells were differentiated into neutrophil-like cells with DMSO then subsequently cultured 
with T. gondii. A, Extracellular DNA release over time was measured by PicoGreen binding 
assay. B, Image collected 6 hr after culture showing PicoGreen positive NET-like structures 
induced by Toxoplasma. The experiments were repeated at least 3 independent times with similar 
results. 
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Figure 3.7. Human peripheral blood neutrophils produce NETs in response to Toxoplasma. 
Purified neutrophils were incubated with 60 nM PMA or tachyzoites (MOI 5: 1) with or without 
cytochalasin D (CytD; 1 M), and release of DNA was measured over time using PicoGreen 
fluorescence assay. * p< 0.05. B-E, Visual confirmation of NET formation in response to 
parasites at 4 hr post-incubation as determined by DNA release (B) in the proximity of parasites 
(C). The merged image in D and the expanded view in E shows extensive parasite entrapment 
within NETs. Results are representative of at least 3 independent experiments. 
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Inhibition of ERK1/2 MAPK activation blocks Toxoplasma-induced NET formation 
Intracellular control of NET formation is still not well understood, but there is evidence for 
involvement of a Raf-MEK-ERK signaling pathway (32). Therefore, we sought to determine if 
Toxoplasma activates the ERK1/2 pathway, and whether this signaling kinase is involved in 
parasite-induced NETosis. Accordingly, we infected human neutrophils with parasites and 
collected samples for Western blot analysis of ERK1/2 activation. Figure 3.8A demonstrates that 
Toxoplasma triggers ERK1/2 phosphorylation as early as 5 min post-infection and that 
phosphorylation was sustained for at least 1 hr. Incubating the cells with medium alone did not 
induce any noticeable phosphorylation of ERK. To determine whether ERK1/2 phosphorylation 
could be blocked, we used U0126, a well-known chemical inhibitor of MEK1/2 that serves as the 
upstream MAPK kinase phosphorylating ERK1/2.  Cells were treated for 2 hr with U0126 then 
infected with RH strain parasites in the continued presence of the inhibitor. As expected, the 
inhibitor completely blocked ERK1/2 phosphorylation triggered by Toxoplasma infection 
(Figure 3.8A). In the same cell lysates, we found high levels of p38 MAPK activation even in the 
absence of parasites, and phosphorylation of this MAPK was not affected by the inhibitor. 
 
We next asked whether inhibition of ERK1/2 activation affected NETosis triggered by 
Toxoplasma. Neutrophils in the presence of MEK1/2 inhibitor or an equimolar concentration of 
DMSO were infected with Toxoplasma and NET formation was monitored. As expected, NETs 
were formed in the presence of parasites in medium alone (Figure 3.8B and C). NETosis was 
decreased when ERK1/2 activation was blocked. Nevertheless, despite the potency of U0126 in 
blocking ERK activation, NET formation was not completely inhibited, and there was no 
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significant difference in the presence and absence of inhibitor at later time points (Figure 3.8C). 
We conclude that optimal NET formation requires ERK1/2 signaling, but that this MAPK is not 
absolutely needed for the formation of extracellular traps.  
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Figure 3.8. Activation of ERK1/2 in response to Toxoplasma controls NET extrusion. A, 
Human peripheral blood neutrophils were incubated in medium alone or with Toxoplasma (Tg) 
alone or with the MEK inhibitor U0126. Western blotting was performed to determine 
phosphorylation of ERK and p38 MAPK, and blots were stripped and re-probed for total MAPK 
levels. Panel B shows images over time from DAPI-stained cells incubated with parasites (top 
panels) or with parasites and ERK inhibitor (bottom panels). Panel C shows NET formation over 
time by neutrophils either treated or not treated with the MEK1/2 inhibitor using the Picogreen 
DNA measuring kit. These experiments were repeated 3 times with similar results. 
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Toxoplasma induces NET formation in vivo 
Finally, we asked whether T. gondii could elicit NET formation by PMNs recruited at a site of 
acute inflammation. To address this question, we employed a Toxoplasma mouse infection 
model in which parasites were administered intranasally and lungs were assessed 6 hrs later for 
parasite colonization, neutrophil recruitment, and NET induction. Lungs from PBS injected mice 
displayed normal pulmonary architecture with minimal cellular infiltration (Figure 3.9A) with no 
detectable myeloperoxidase (MPO) positive cells (Figure 3.9B), and no Toxoplasma Ab-reactive 
cells (Figure 3.9C). However, lungs from infected mice lost normal pulmonary architecture and 
this was associated with massive cellular infiltration (Figure 3.9D). The infiltrating cells were 
mostly composed of neutrophils, as determined by expression of MPO in serial sections (Figure 
3.9E). Large numbers of parasites were also present in the lung tissue (Figure 3.9F). Therefore, 
in this in vivo model of parasite-induced inflammation, neutrophils and Toxoplasma are brought 
into close proximity in infected tissue. Next, bronchoalveolar lavage fluid (BALF) was collected 
from the lungs of PBS administered and Toxoplasma infected mice. After a spin-down step to 
remove cells, supernatants were tested for dsDNA as a measure of NET formation. Samples from 
Toxoplasma-infected mice displayed greatly increased amounts of dsDNA compared to PBS-
injected control mice (Figure 3.9G). We conclude that in vivo infection signals recruitment of 
neutrophils that then release extracellular traps in response to the parasite. 
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Figure 3.9 (previous page). Neutrophils form NETs in vivo during Toxoplasma infection. 
Mice were intranasally injected with PBS as a control (A-C) or intranasally infected with PTG 
strain parasites (D-F). 6 hr later, lungs were collected, sectioned and serial sections were stained 
with H&E (A, D), Ab to myeloperoxidase (MPO; B and E), and an anti-T. gondii antiserum 
(TOXO; C and F). In panel G, mice were intranasally administered PBS or tachyzoites, then 6 hr 
later BALF was collected and dsDNA was measured in cell-free supernatants. These 
experiments were repeated three times with similar results. 
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Discussion 
Neutrophil extracellular traps have recently emerged as powerful weapons used by PMN to 
combat microbial pathogens. The results of the present study demonstrate that both mouse and 
human PMN undergo NET production in response to the protozoan pathogen T. gondii. We 
report that neutrophils respond to Toxoplasma infection by releasing extracellular traps and that 
DNA release is not dependent on active invasion by the parasite or host cell phagocytic function. 
PMN formed extracellular traps in response to all 3 clonal lineages of T. gondii. We also show 
parasite-induced NET release involves a MEK-ERK pathway. Finally, we found evidence for 
NET formation during in vivo infection with Toxoplasma. 
 
Neutrophil extracellular traps are primarily composed of DNA, histones and other antimicrobial 
components forming an extracellular mesh that can trap and inactivate pathogens (38). In 
addition to histones, the antimicrobial components have been shown to include bacterial 
permeability-increasing protein (BPI), myeloperoxidase, as well as neutrophil elastase (9, 39) 
that are effective in killing Gram-positive and Gram-negative bacteria (9, 33). It has also been 
shown that NETs are an important protective mechanism during fungal infection, and that they 
contain calprotectin, a molecule involved in defense against Candida albicans (16, 34). We also 
obtained evidence for tachyzoite killing that depended upon formation of NETs. At present we 
do not know what specific components of the NETs mediate parasite killing. 
 
We hypothesize that another major functional consequence for NET formation in the context of 
T. gondii infection may be that they interfere with host cell invasion by ensnaring parasites. As 
an obligate intracellular protozoan, it is essential for Toxoplasma to establish itself within its 
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intracellular niche so that it can scavenge the host cell for essential nutrients enabling parasite 
survival and replication. Therefore, any parasite entrapped within a NET will ultimately die as a 
result of failure to successfully invade a host cell.   
 
The results reported here are amongst the first to show NET formation in response to protozoan 
parasites. Elsewhere, it has been reported that Leishmania triggers NET formation. For the case 
of Leishmania amazonensis, NET entrapment resulted in parasite killing partly dependent upon 
presence of histones (18). Other studies with L. donovani promastigotes showed formation of 
NETs, but in this case parasites evaded killing in dependence upon expression of 
lipophosphoglycan (17). There is also evidence for Plasmodium falciparum-associated NET 
formation, and elicitation of anti-nuclear antibodies as a result of DNA release may play a role in 
pathology in infected children (40). Collectively, these studies contribute to an emerging view 
that release of extracellular traps by neutrophils is a critical innate defense mechanism that is 
elicited by a broad range of microbial pathogens.   
 
NETosis is a newly recognized pathway of programmed fatality that enables neutrophils to exert 
anti-microbial activity even after the cells have died. The process of NETosis appears to involve 
histone citrullination-dependent chromatin decondensation, disintegration of the nuclear 
membrane, followed by mixing of nuclear and cytoplasmic effector proteins before eventual 
release to the extracellular milieu (33, 41-43). The molecular mechanisms underlying this novel 
type of programmed cell death is an area of intense investigation (44). NETosis has been shown 
to depend on the generation of reactive oxygen species and a fully functional NADPH complex 
(45). Neutrophils isolated from patients with chronic granulomatous disease (CGD), who have 
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defects in NADPH oxidase activity, fail to exhibit NET formation (33, 46). Also, 
myeloperoxidase and neutrophil elastase have been shown to regulate the formation of 
neutrophils extracellular traps (47, 48). Recently, Hakkim et al. identified a signaling pathway 
involved in extracellular trap formation that involves a Raf-MEK-ERK pathway (32). We 
previously reported that Toxoplasma triggers JNK MAPK activation in neutrophils (28), 
prompting us to examine whether ERK activation could mediate parasite-induced NET 
extrusion. Indeed, we found evidence for parasite-triggered ERK phosphorylation, and 
pharmacological inhibition of this cascade blocked the NET response to T. gondii infection. 
 
We considered the possibility that NET formation was triggered from within infected cells. 
However, blocking invasion with cytochalasin D had no effect on formation of NETs. In 
addition, soluble sonicated parasite lysate could also trigger NET release, although not as 
efficiently as live parasites (data not shown). Taken together, it seems most likely that production 
of extracellular traps is mediated by factors released by extracellular tachyzoites. Nevertheless, 
while cytochalasin D blocks invasion, parasites are still able to attach to the host cell surface and 
discharge proteins into the host cell (49, 50). It is possible that this phenomenon is involved in 
stimulating NET extrusion.       
 
The in vivo relevance of NET formation during infection with Toxoplasma and other 
microorganisms is not yet clear. However, we used a mouse intranasal infection model to obtain 
evidence for a role of NET formation in innate pulmonary defense against T. gondii. While this 
is not a natural route of infection, it is nevertheless well established that parasites disseminate to 
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the lungs and cause pneumonia in humans and animals (51, 52). Furthermore, MyD88-dependent 
recruitment of neutrophils to the lamina propria occurs after oral infection with the parasite and 
there is evidence that neutrophils protect against infection (53-55). Whether protection is a result 
of interference with invasion by NET entrapment or other neutrophil antimicrobial functions is 
not known, and may be difficult to determine until more is known about control of NET 
extrusion. Regardless, our data and those of others demonstrate that NET release is an event that 
is triggered upon encounter with both prokaryotic and eukaryotic microbial pathogens. How this 
functions in host defense against infection or possibly might contribute to the disease process 
will be important issues to address in the future.  
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CHAPTER 4 
Neutrophil Depletion during Toxoplasma gondii Infection Leads to Impaired Pulmonary 
Immunity and Lethal Inflammatory Responses* 
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Abstract 
Considerable confusion surrounds the role of polymorphonuclear leukocytes (PMN) in mouse 
models of infection. This is because the classical monoclonal antibody (mAb) used to deplete 
neutrophils (RB6.8C5) recognizes Ly6C/G (Gr-1), which is expressed by plasmacytoid DCs and 
inflammatory monocytes, in addition to PMNs. Here, we evaluated the importance of neutrophils 
during Toxoplasma gondii infection using the mAb 1A8 that recognizes Ly6G and is therefore 
neutrophil specific. We determined that neutrophils are required for survival of infected mice in 
the acute phase of infection. No differences in parasite burden were observed between control 
and neutrophil-depleted infected mice as determined by PCR and immunohistochemical staining. 
Histopathological analysis of intestine, liver, brain and spleen failed to reveal any overt 
differences between neutrophil depleted and control groups. However, histopathology of the 
lungs from neutrophil-depleted and infected mice showed numerous foci of cellular infiltrates. 
Flow cytometric analysis and immunohistochemistry revealed that these cells were composed 
mostly of CD4
+
 T cells. Interestingly, IL-12 and TNF-α levels were higher in bronchoalveolar 
lavage fluid of neutrophil depleted mice. In addition, cells from tracheobronchial lymph nodes 
draining the lungs of neutrophil depleted mice secreted highly elevated levels of IL-12, TNF-α 
and IFN-γ. Immunophenotyping revealed that CD4+, CD8+ T cells and CD11b+ cells were the 
source of these cytokines. Dendritic cells taken from neutrophil depleted and infected mice are 
more activated and present antigen more efficiently. Taken together, these data indicate a role for 
neutrophils as immunomodulatory cells that influence the outcome of infection with T. gondii. 
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Introduction 
Cells of the immune system play important roles in fighting infection and disease. One of the 
major first-responders to any source of foreign insult are polymorphonuclear leukocytes, better 
known as neutrophils (1). They are the first cells to reach a site of infection or inflammation in 
response to inflammatory signals, thus rendering them important in almost all immune responses. 
Resolution of inflammation usually involves the apoptosis of neutrophils and their engulfment by 
phagocytes (2). 
 
Toxoplasma gondii is an obligate intracellular parasite that poses minimal risk to 
immunocompetent individuals but can wreak havoc in immunocompromised hosts (3, 4). In 
addition to the risk associated with compromised hosts, the parasite can cause birth defects or 
even abortions in congenital infections (5). The parasite normally induces a Th1 type immune 
response, characterized by the production of IL-12 and IFN-, which keeps the infection in check 
and forces the parasite into a dormant cyst state that has the potential of reactivating at later 
stages in life causing encephalitis (6-9). 
 
Neutropenic mice are extremely susceptible to a wide range of infectious agents. Mice depleted 
of neutrophils, using antibody to the neutrophil-associated marker Gr-1 fail to control infections 
with Aspergillus fumigates, Candida albicans, Chlamydia trochomatis, Legionella pneumophilia, 
Leishmania infantum, Leishmania major, Toxoplasma gondii and Listeria monocytogenes among 
other pathogens (10-25). Mice depleted of Gr-1
+
 cells and infected with T. gondii succumb to the 
parasite within ten days postinfection with a highly dysregulated cytokine profile. This 
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dependency on Gr-1
+
 cells for survival is critical in the first few days of infection, since mice 
depleted of Gr-1
+
 cells starting at 6 days postinfection still survive acute infection. In addition, 
these Gr-1
+
 depleted mice exhibit increased parasite burdens with exacerbated lesions in multiple 
organs (24). In the context of a Toxoplasma infection, neutrophils produce a variety of 
chemokines and cytokines that can influence immune responses. Of particular importance is the 
production of IL-12, TNF-α, MIP-1β, MIP1-α in human neutrophils, and MyD88-dependent IL-
12 and MCP-1 in mouse neutrophils in response to parasite stimulation (26, 27). Also of interest 
is the fact that during a Toxoplasma infection, neutrophils with prestored IL-12 are recruited to 
the site of infection (28). 
 
Rendering mice neutropenic using antibody-mediated depletions with the anti-Gr-1 antibody has 
been the standard protocol to achieve depletions (29). However, recent evidence suggests that the 
surface marker Gr-1 is also expressed on plasmacytoid dendritic cells in addition to CCR2
+
 
inflammatory monocytes (30, 31). A more recent study makes use of a recently available 
monoclonal antibody that targets the neutrophil-specific Ly6G surface molecule (32). This 
antibody is neutrophil specific and should not deplete other Gr-1
+
 cell populations. 
 
Here we show that we can effectively and efficiently deplete mice of neutrophils using the 1A8, 
anti-Ly6G depleting antibody. We also show that mice depleted of neutrophils succumb to 
infection within 10 days. Depletion of neutrophils however had no statistically significant effects 
on parasite burden in both lymphoid and non-lymphoid tissues. Neutrophil depletion, followed 
by infection, led to an increase in the cytokine levels of IL-12, TNF-α, IL-10, and IFN- 
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observed in bronchoalveolar lavage fluid (BALF) and tracheobronchial lymph node (TLN) 
culture supernatants. This overproduction of cytokines was due mostly to an increased and 
activated population of CD4
+
 T cells and also due to an increased production of cytokines from 
CD8
+
 T cells and CD11b
+
 cells in neutrophil depleted mice. We also observed that CD11c
+
 cells 
from neutrophil depleted and infected mice were more activated and led to an increased T cell 
proliferative response when pulsed with OVA and incubated with OT-II OVA specific CD4
+
 T 
cells.  
 
Materials and Methods 
Mice 
Female C57BL/6 mice were purchased from Taconic Farms (Germantown, NY, USA) and 
C57BL/6-Tg(TcraTcrb)425Cbn/J (OT-II) breeders were purchased from The Jackson Laboratory 
(Bar Harbor, ME, USA) and used at 6-8 wk of age. All mice were maintained in the Transgenic 
Mouse Core Facility at the Cornell University College of Veterinary Medicine, which is 
accredited by the American Association for Accreditation of Laboratory Animal Care. 
 
Depletions, parasites and infections 
Mice were rendered neutropenic by injections with anti-1A8 (anti-Ly6G, Bioxcell, West 
Lebanon, NH, USA) and anti-Gr-1 (RB6C6.8C5 hybridoma originally provided by 
R. L. Coffman, Dynavax Technologies Corporation, Berkeley, CA, USA) monoclonal 
antibodies. Depletion of IL-12 in vivo was achieved by injecting mice with anti-IL12 antibody 
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(hybridoma originally provided by G. Trinchieri, NCI, Frederick, MD, USA). Mice were injected 
with 1 mg of anti-1A8, 200 µg of anti-RB6 or 200 µg of anti-IL-12 antibodies every 48 hrs 
starting at day -2 prior to infection and up to day 8 post-infection. Control animals were injected 
with 1 mg of Rat IgG antibody.  
 
ME49 bradyzoite cysts were maintained in Swiss Webster mice as previously described (33). 
Brains of chronically infected mice were collected, brain homogenate obtained and cysts 
counted. Mice were infected orally with 20 cysts in a 250 µl volume using an oral gavage needle.  
Soluble tachyzoite antigen (STAg) was prepared as previously described (33). 
 
Histology and Tissue collection 
Mice were euthanized at days 8 or 9 post-infection and dissected for tissue collection. Gut, livers, 
lungs, brains and spleens were collected and fixed in 10% (wt/vol) buffered formaldehyde. 
Samples were then progressively dehydrated in ethanol, cleared with xylene, and embedded in 
paraffin for further staining with hematoxylin and eosin or anti-CD3. Samples were also 
embedded in OCT solution for cutting on a cryotome. 
 
BALF collection and Lung digestion 
Bronchoalveolar lavage fluid (BALF) and lungs were collected from day 8 antibody injected and 
infected mice. Briefly, after the mice were euthanized, a small tracheal incision was made and 
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lung was washed using PBS with a 200 µl loading tip for a total of 5 washes. The resulting fluid 
was separated by centrifugation into cells for flow cytometric analysis and supernatant for 
cytokine measurement analysis. Lungs of day 8 infected mice were collected and mechanically 
sliced using a razor blade into 1 mm thick sections. Resulting sliced sections were further 
enzymatically digested using both Liberase at 0.2 mg ml
-1
 (Roche Diagnostics,  
Mannheim, Germany) and Collagenase at 5 mg ml
-1
 (Sigma-Aldrich, St Louis, MO, USA) for 1 
hr at 37°C while gently rocking. Cells were then washed 3X in Hanks Balanced Salt Solution, 
filtered using a 70 micron filter (BD Falcon, Franklin Lakes, NJ, USA) and subjected to multi-
colored flow cytometric analysis.  
 
STAg restimulation and cytokine measurement 
Mesenteric lymph nodes (MLN), spleens (SPL) and tracheobronchial lymph nodes (TLN) were 
collected from day 8 mice and single cell suspensions obtained by gently mashing. Cells were 
filtered using a 70 micron filter and red blood cells lysed using ACK lysis buffer (Gibco, Grand 
Island, NY, USA). Cells were seeded onto a 96 well plate (BD Falcon, Franklin Lakes, NJ, USA) 
at a concentration of 2 x 10
6
 cells per well in a 100 µl volume in complete DMEM (cDMEM) 
consisting of 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 100 U ml
−1
 penicillin, 
100 μg ml−1 streptomycin, 30 mM HEPES, (all purchased from Invitrogen Life Technologies, 
Carlsbad, CA, USA), 10% bovine growth serum (Hyclone, Logan, UT, USA) and 0.05 mM β-
mercaptoethanol. STAg was added in a 100 µl volume and cell-free supernatants were collected 
after 24 hrs in culture. IL-12p40 was measured in cell-free supernatants as previously described 
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(33). IL-10, TNF-, IFN- and IL-17 were measured in cell-free supernatants according to the 
manufacturer’s instructions (eBioscience, San Diego, CA, USA).  
 
Toxoplasma burden measurements 
DNA extraction from tissue samples, including the gut, brain, liver, lungs and spleen, was 
performed using DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia, CA) following the 
manufacturer’s instructions. Briefly, after 20 mg of tissue samples were digested in lysis buffer 
with Proteinase K at 55C, DNA was extracted, washed, and eluted in 200 l of elution buffer.  
 
Real-time PCR was performed targeting the highly conserved 35-fold-repetitive B1 gene in T. 
gondii (34). A 25 l reaction mixture was prepared using 2X Power SYBR Green PCR Master 
Mix (Applied Biosystems, Foster City, CA) with 0.3 M of forward primer (5’-GGA GGA CTG 
GCA ACC TGG TGT CG-3’) and reverse primer (5’-TTG TTT CAC CCG GAC CGT TTA 
GCA G-3’) (35). Real-time PCR was carried out in an Applied Biosystem 7500 Fast Real-time 
PCR System (Applied Biosystems, Foster City, CA) with the following thermal cycling 
conditions: 50C for 2 min, 95C for 10 min, followed by 40 cycles at 95C for 15 s and 60C 
for 1 min.  All PCR amplifications were subjected to dissociation analysis to confirm the 
specificity of amplification. Quantification of the parasites was accomplished by using a standard 
curve constructed with a series of known quantity of the RH strain of T. gondii over a range of 6 
logs corresponding to 10
5
 to 1 parasite per reaction. Uninfected tissues were used as negative 
controls and distilled sterile water used as no template controls.  
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Flow cytometric analysis and intracellular staining 
Single-cell suspensions were incubated for 30 min at 4°C with FACS buffer (PBS, 1% bovine 
growth serum and 0.01% NaN3) containing 10% normal mouse serum to block Fc receptor 
binding. Samples were then centrifuged and cells resuspended in FACS buffer containing 
fluorochrome-conjugated antibodies for 30 min at 4°C. Antibodies used in this study were: anti-
Gr-1 FITC (BD Biosciences, San Jose, CA, USA), PE-conjugated anti-Ly6G (BD Biosciences), 
PE-conjugated anti-CD62L, CD25, CD11b, CD11c, F4/80, NK1.1 and CD69 (BD Biosciences), 
allophycocyanin-conjugated anti-CD4 and CD8 (BD Biosciences), PE-conjugated anti-IFN- 
(eBioscience, San Diego, CA, USA), and PE-conjugated anti-IL-10 (eBioscience). Cells were 
then washed and resuspended in FACS buffer and collected on a BD FACSCalibur flow 
cytometer. Data analysis was performed using FlowJo software (Tree Star, Ashland, OR, USA). 
For intracellular staining, after cells were surface stained for membrane antigens, they were 
permeabilized and stained for intracellular cytokines. 
  
OT-II T cell proliferation studies 
To obtain DC, lungs from day 8 infected mice were excised and single-cell suspensions were 
obtained as described above. Cells were centrifuged at 300 × g for 10 min at 4°C. The pellet was 
resuspended in MACS buffer (PBS, 0.5% BSA and 2 nM EDTA) and MACS anti-CD11c 
magnetic beads (Miltenyi Biotec, Auburn, CA, USA) were added. The sample was mixed and 
incubated for 15 min at 4°C. Cells were washed using MACS buffer and centrifuged at 300 
× g for 10 min. The cell pellet was resuspended in MACS buffer and CD11c-positive and 
negative fractions were separated using an AutoMACS Separator. The same protocol was used to 
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obtain CD4
+
 T cells starting with spleens from OT-II mice and using anti-CD4 magnetic beads. 
CD4
+
 T cells were stained with 5-(and 6-)carboxyfluorescein diacetate succinimidyl ester 
(CFSE) (Molecular Probes, Carlsbad, CA, USA) according to the manufacturer's instructions. 
Briefly, cells were resuspended in PBS with 0.1% BSA and CFSE stock solution was used to 
yield a final concentration of 10 μM. Cells were incubated at 37°C for 10 min. The staining was 
quenched by adding five volumes of ice-cold cDMEM followed by incubation on ice for 5 min. 
CFSE-stained cells were further washed for a total of three washes using cDMEM. DC were 
pulsed with OVA 323-339 peptide (2µg ml
-1
 ) and T cells were incubated together at a ratio of 
1:10 for 4 days before assayed for CFSE peak dilutions. 
 
Immunofluorescence microscopy 
OCT embedded lungs were sliced on a cryotome to a thickness of 8 µm then collected on 
charged slides, acetone fixed, and frozen at -80°C until ready to use. After slides were thawed to 
room temperature, samples were outlined with an Aqua Hold Pap Pen (Fisher Scientific, 
Pittsburgh, PA, USA) then blocked for 30 min at room temperature using 2X casein (Vector 
Labs, Burlingame, CA, USA) in PBS containing normal mouse serum 
(JacksonImmunoResearch, West Grove, PA, USA). Anti-CD4 FITC conjugated antibody 
(eBioscience, San Diego, CA, USA) was added in block solution for 2 hrs at room temperature 
in a dark and humid chamber. After the antibody incubation, slides were washed twice in PBS 
then mounted with ProLong Antifade containing 4′,5-diamidino-2-phenylindoleI (Molecular 
Probes). Images were collected with an Olympus BX51 fluorescence microscope equipped with 
a DP 70 camera using Olympus DP controller software and Olympus DP manager software. 
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Statistical analyses 
Statistical analyses were performed using the Prism Software. Unpaired, two-tailed t-tests were 
used to determine statistical significance. P values <0.05 were considered significant.  
 
Results 
Neutrophil-depleted mice succumb to Toxoplasma infection 
Considerable confusion surrounds the role of antibodies in the depletion of neutrophils. 
Depletion of neutrophils during a Toxoplasma infection has routinely been performed using an 
anti-Gr-1 (RB6.8C5) antibody (25, 36). However, it has recently been shown that other cells can 
also express Gr-1 molecules on their surface, namely inflammatory monocytes and plasmacytoid 
dendritic cells (30, 31). 1A8 antibody has been developed as a neutrophil specific antibody that 
recognizes the Ly6G surface molecule specifically found on neutrophils. Figure 4.1A shows a 
schematic representation of our depleting protocol, employing anti-Ly6C/G, anti-Ly6G and 
control IgG antibodies. Mice were treated with antibodies and infected with 20 cysts of ME49 
orally, then on day 4 postinfection we looked at the percentage of cells staining positive for 
neutrophil markers in both spleens (SPL) and mesenteric lymph nodes (MLN). Panels B-E show 
surface staining of single cell suspension from the spleen and mesenteric lymph nodes of 
depleted and non-depleted infected mice. The double positive, RB6
+
/1A8
+
, neutrophil population 
is absent in the SPL and MLN of 1A8 treated mice (C and E), but still present in the SPL and 
MLN IgG treated mice (B and D), confirming depletion in vivo. To confirm depletions 
systemically, we also stained for elastase, a neutrophil marker, in tissues collected from control 
and neutrophil depleted animals. Figure 4.1F and G shows elastase staining in the gut of day 8 
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infected mice in both IgG and 1A8 treated mice. Neutrophil treated mice had no positive cells for 
elastase (Figure 4.1G), whereas elastase positive cells were visible in non-depleted mice (Figure 
4.1F, arrows). Depletion of mouse neutrophils was also confirmed by performing blood smears 
using peripheral blood collected from control and neutrophil depleted mice (Data not shown).  
 
We then asked whether neutrophil depleted mice succumbed to Toxoplasma infection. As shown 
in Figure 4.2A, in vivo depletion of neutrophils with the 1A8 antibody (dotted line) renders the 
mice more susceptible to infection with 100% mortality by day 10 postinfection. Mice treated 
with IgG antibody (solid line) survived past day 30 postinfection underscoring the importance of 
neutrophils in the early control of Toxoplasma infection. RB6.8C5 (dashed line) treated mice 
also succumbed to infection, albeit with different kinetics, due perhaps to a role that 
inflammatory monocytes can play. Using such a high dose of depleting antibody raised concerns 
that the mice might be undergoing organ failure as a result of the high antibody dose and not the 
infection. To address this question, we treated mice with both IgG and 1A8 antibodies at a dose 
of 1 mg but did not infect with Toxoplasma. As can be seen in Figure 4.2B, both groups survived 
antibody injections ruling out any role for the dosage of antibody on mouse mortality. 
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Figure 4.1 (previous page). 1A8 treatment completely depleted neutrophils in vivo. Mice 
were depleted with 1 mg dose of anti-Ly6G, 200 µg dose of anti-Ly6C/G, 200 µg dose of anti-
IL-12 and injected with 1 mg dose of control rat IgG. A, Injections were administered 48 hrs 
prior to infection with 20 cysts of ME49, and then booster injections were administered every 48 
hrs thereafter. B, presence of neutrophils (RB6
+
/1A8
+
) in the spleens of non-depleted infected 
mice. C, confirmed depletion of neutrophils in the spleens of depleted infected mice. D, presence 
of neutrophils (RB6
+
/1A8
+
) in the mesenteric lymph nodes of non-depleted infected mice. E, 
confirmed depletion of neutrophils in the mesenteric lymph nodes of depleted infected mice. All 
samples shown in B-E are from day 4 postinfection. F, presence of elastase positive cells in the 
gut of non-depleted infected mice. G, lack of elastase positive staining in the gut of depleted 
infected mice. Experiments were repeated at least 3 times with similar results. 
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Figure 4.2. Mice depleted of neutrophils in vivo are more susceptible to Toxoplasma 
infection. A, survival curves of neutrophil-depleted (dotted line), antibody-control treated (solid 
line), or RB6 treated (dashed line) and infected mice. B, survival curves of neutrophil-depleted 
and antibody-control treated and non-infected mice. Four mice were used for each treatment 
group. Experiments were performed at least 3 times with similar results. 
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Neutrophil-depleted and control-injected mice have comparable parasite burdens 
We then wondered as to whether neutrophil-depleted mice had a deficit in their capacity to 
control the replication of the parasite, resulting in mortality. We collected tissues at day 8 
postinfection from IgG and 1A8 treated and infected mice. We also treated mice with anti-IL-12 
antibody to deplete IL-12, as it has been shown to be important for control of parasite replication 
in vivo (37). As can be seen in Figure 4.3, there were no significant difference between control 
(IgG, black circles) or neutrophil-depleted (1A8, white circles) and infected mice in gut (A), 
liver (B), brain (C), spleen (D) and lung tissues (E). However, in all tissues tested, there were 
significantly higher numbers of parasites in the IL-12 depleted mice (IL-12, grey circles). 
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Figure 4.3 (previous page). Neutrophil-depleted and control-treated and infected mice have 
equivalent parasite burden in gut, liver, brain, spleen and lung. DNA isolated from tissues 
was subjected to real-time PCR targeting the highly conserved 35-fold-repetitive B1 gene in T. 
gondii. Samples were collected from mice treated with anti-Ly6G, anti-IL12 and control IgG 
antibodies and infected with 20 cysts of ME49. No significant differences were observed 
between the control and neutrophil-depleted groups, however, significant differences were 
observed between mice depleted of IL-12 and all other groups. All data shows toxoplasma 
burden per gram of tissue in A, gut, B, liver, C, brain, D, spleen and E, lungs. ns means not 
significant, * is a p value in the range of 0.01 to 0.05, ** 0.001 to 0.01 and *** is a p-value of< 
0.001. Experiments were repeated at least 3 times with similar results. 
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Neutropenic infected mice have abnormal lung pathology 
To examine why mice were susceptible to infection, we collected tissues from all major organs 
of depleted and infected mice as well as non-depleted and infected mice immediately prior to 
death, usually around day 8. Figure 4.4 shows representative images from Hematoxylin & Eosin 
(H&E) stains for gut (A and B), spleen (C and D), liver (E and F) and brain (G and H). At these 
sites, there were no differences between control (A, C, E and G) and depleted (B, D, F and H). 
Differences however were observed in the lungs of neutrophil-depleted and infected mice and 
representative images are shown in Figure 4.5. As can be seen in Figure 4.5B, lungs from 
neutrophil-depleted and infected mice show increased pulmonary congestion and an infiltration 
of cells at various foci (red circles), when compared to control-treated and infected mice (Figure 
4.5A). 
 
 
 
 
 
 
 
 
 
 146 
 
Figure 4.4. Neutrophil-depleted mice exhibit no differences in lesions in both lymphoid and 
non-lymphoid tissues. Tissues from gut (A and B), spleen (C and D), liver (E and F) and brain 
(G and H) were collected from control treated (A, C, E and G) and neutrophil-depleted (B, D, F 
and H) animals at day 8 postinfection with 20 cysts of ME49. Samples were fixed according to 
standard lab protocols and stained for hematoxylin and eosin. Experiments were repeated at least 
3 times with similar results. 
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Cellular infiltrates in neutrophil-depleted lungs are mostly T cells 
We speculated as to the composition of the cellular infiltrates in Figure 4.5B, and performed 
flow cytometry to determine their composition. Immunohistochemical analysis showed that these 
cells were mostly CD3
+
 cells indicating that they were T cells (Figure 4.5D). Further analysis 
showed that these cells were mostly CD4
+
 T cells (Figure 4.5H). To further characterize the 
cellular infiltrates, we collected bronchoalveolar lavage fluid from control and neutrophil-
depleted mice at day 8 postinfection and subjected the cells to flow cytometric analysis. As can 
be seen from Figure 4.6A, neutrophil-depleted mice (white bars) had a much higher percentage 
of CD4
+
 T cells when compared to control treated and infected mice (black bars). We also 
performed analysis on lung digests from control and neutrophil-depleted and infected mice. 
Lungs from mice were mechanically and enzymatically digested to obtain single-cell 
suspensions. Resulting cell populations were subjected to flow cytometric analysis. Figure 4.6B 
shows a modest increase in the percentage of CD4
+
 T cells in lung digests from neutrophil 
depleted mice. Lungs of these mice also have slightly elevated percentage of macrophages and B 
cells evidenced by increased staining for F4/80 and B220 respectively. 
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Figure 4.5 (previous page). Lungs of neutrophil-depleted mice have infiltrating cellular 
foci. Mice were treated with control rat IgG antibody or neutrophil depleting antibody and 
infected with 20 cysts of ME49. At day 8 postinfection, lungs were collected, fixed, paraffin 
embedded and stained for H and E and CD3. OCT embedded lungs were stained for CD4. A, 
Lungs from IgG treated mice have normal pulmonary architecture. B, Lungs from 1A8 treated 
mice are congested with various cellular foci spread throughout (red circles). C, Control treated 
mice have minimal CD3 positive cells. D, Lungs from neutrophil depleted mice have higher 
numbers of cells positive for CD3. E, F and G, CD4, DAPI and merged images for lungs from 
control treated mice. H, I and J, higher numbers of CD4
+
 T cells in the lungs of neutrophil 
depleted mice. All experiments were repeated at least three times with similar results. 
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Figure 4.6. Neutropenic mice have higher percentage of CD4
+
 T cells. Control treated and 
neutrophil-depleted and infected mice were euthanized on day postinfection and BALF and lungs 
collected for flow cytometric analysis for cellular composition. Macrophages were stained with 
F4/80, natural killer cells with NK1.1, dendritic cells with CD11c, T cells with CD4 and CD8, 
neutrophils with 1A8 and Gr-1. A, BALF of neutrophil-depleted mice have almost a 3 fold 
increase in the percentage of T cells staining positive for the CD4 marker. B, Increase in 
percentage of CD4
+
 T cells in lung digests from neutrophil depleted mice. Experiments were 
performed with 4 mice per group and repeated at least 3 times with similar results. 
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Neutrophil depleted mice have impaired pulmonary cytokine profiles 
Given that no major difference in parasites replication was observed, we looked at whether 
control and depleted mice had different cytokine profiles. We collected cell-free supernatants 
from BALF and subjected the samples to cytokine measurements by ELISA. Supernatants from 
neutrophil-depleted mice had elevated levels of IL-12 and TNF-α when compared to control 
treated mice (Figure 4.7). To further characterize the recall immune response, we performed 
restimulation assays with soluble tachyzoite antigen (STAg) on single-cell suspensions isolated 
from spleens (SPL), mesenteric lymph nodes (MLN) and tracheobronchial lymph nodes (TLN). 
Figure 4.8 shows ELISA data from cell-free supernatants obtained from STAg restimulations for 
24 hrs ex vivo. All cultures from neutrophil depleted mice (white bars) in TLN cultures had 
higher levels of cytokines when compared to control treated mice (black bars) in every cytokine 
tested. We observed higher levels of IL-12 (A), IL-10 (B), TNF-α (C) and IFN- (D). 
Interestingly, this difference is localized to the lungs since restimulation assays with samples 
collected from spleens and mesenteric lymph nodes had no differences between control and 
depleted groups. 
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Figure 4.7. Levels of IL-12 and TNF-α are increased in BALF supernatants of neutrophil-
depleted mice. BALF collected from control-treated or neutrophil-depleted and infected mice 
was separated by centrifugation into cells and cell-free supernatants. Supernatants were then 
tested by ELISA for cytokine levels. Neutrophil-depleted mice have higher levels of both IL-12 
and TNF-α when compared to control-treated mice (Empty bars vs solid bars). Experiments were 
repeated at least twice with similar results. 
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Figure 4.8. Tracheobronchial lymph node restimulation cultures have higher cytokine 
levels in neutrophil-depleted and infected mice. Single-cell suspensions of tracheobronchial 
lymph nodes (TLN), spleens (SPL) and mesenteric lymph nodes (MLN) from control-treated or 
neutrophil-depleted and infected mice were restimulated ex vivo with soluble tachyzoite antigen 
(STAg) at a range of concentrations (0 µg ml
-1
 - 50 µg ml
-1
). 24 hr supernatants were collected 
and tested by ELISA for cytokines. A, IL-12 levels. B, IL-10 levels. C, TNF- levels. D, IFN- 
levels. E and F show IFN- levels in SPL and MLN respectively. All experiments were repeated 
at least twice with similar results. 
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CD4
+
 T cells produce IL-10 and IFN- 
Given that both BALF and lungs digests of neutrophil-depleted and infected mice have higher 
percentages of CD4
+
 T cells, and also given that there are more cytokines produced in these mice 
as well, we asked whether these CD4
+
 T cells are the source of cytokine. To address this 
question, we performed surface staining along with intracellular cytokine staining on cells 
collected from single-cell suspensions from TLN preparations from control treated and 
neutrophil-depleted mice. As can be seen in Figure 4.9, and reiterating data from BALF and lung 
digests, neutrophil-depleted and infected mice had a higher percentage of CD4
+
 T cells, and a 
subset of these cells were positive for IL-10 and IFN-. Figure 4.9 B and D shows intracellular 
cytokine staining on CD4
+
 T cells for IL-10 and IFN- respectively, on cells collected from 
neutrophil-depleted mice, while panels A and C show the same data for control treated samples. 
CD8
+
 T cells from depleted and infected mice were also found to produce more cytokine than 
their counterparts in non-depleted mice (Figure 4.9E). However their percentages were similar in 
both groups (Figure 4.6B). Intracellular staining for IL-10, IL-17, TNF-α and IFN- and surface 
staining for CD11b and CD11c showed that CD11b cells from depleted mice produced more IL-
12 and TNF-α while cytokine levels from CD11c cells were comparable in both groups. It was 
also notable that the activation status of CD4
+
 T cells from neutrophil-depleted mice was 
different from that of CD4
+
 T cells from control mice. This was evidenced by the expression of 
CD25 and CD69, where these markers were modestly elevated on CD4
+
 T cells from neutrophil-
depleted mice (Figure 4.10 E and F) compared to CD4
+
 T cells from control mice (B and C). No 
differences in CD62L expression on CD4
+
 T cells was observed between both groups (A and D). 
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Figure 4.9. T cells are the source of IFN- and IL-10 in depleted mice. Tracheobronchial 
lymph nodes were collected from IgG and 1A8 treated and infected mice and single cells 
suspensions were collected. Cells were incubated with Golgi plug for 4 hours before staining. 
Surface staining was performed for CD4, CD8, CD11c and CD11b while intracellular staining 
was performed for IL-10, IL-12, TNF-α and IFN-. A, IL-10 production by cells from IgG 
treated mice. B, IL-10 production by cells from 1A8 depleted mice. C and D, intracellular IFN- 
staining from IgG and 1A8 treated mice, respectively. E, TNF-α, IL-12, IL-10 and IFN- 
production by CD11c, CD11b and CD8
+
 T cells. Experiments were repeated at least twice with 
similar results. 
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Figure 4.10. CD4
+
 T cells from tracheobronchial lymph nodes from 1A8 depleted mice 
display increased levels of activation. Mice were treated with IgG or 1A8 antibodies and 
infected with 20 cysts of ME49. At day 8 postinfection, tracheobronchial lymph nodes were 
collected and single cell suspension obtained. Cells were stained for surface markers. Events 
collected were gated on forward and side scatter. A, B and C, CD62L, CD25 and CD69 staining 
on CD4
+
 T cells from control IgG treated mice. D, E and F, CD62L, CD25 and CD69 staining on 
CD4
+
 T cells from 1A8 treated mice. Experiments were repeated at least 3 times with similar 
results. 
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Dendritic cells from neutrophil depleted mice prime T cells more effectively 
Since evidence indicated that CD4
+
 T cells from neutrophil-depleted mice were greater in 
number, we asked whether dendritic cells from neutrophil-depleted mice were more effective at 
activating T cell proliferation. Lungs from infected, control and neutrophil-depleted mice were 
collected then mechanically and enzymatically treated to obtain single-cell suspensions. Cells 
were then further subjected to magnetic cell sorting using anti-CD11c beads to isolate dendritic 
cells. In parallel, OT-II CD4
+
 T cells were similarly isolated using anti-CD4 magnetic beads 
from splenocytes of OT-II mice, whose CD4
+
 T cells are specific for OVA peptide amino acid 
sequence 323-339. Dendritic cells were incubated with OVA peptide (2 µg ml
-1
) for 4 hrs at 
37°C, then washed extensively and CFSE stained OT-II CD4
+
 T cells added at a ratio of 10:1. 
After 4 days in culture, cells were collected and stained for CD4 and analyzed using a flow 
cytometer for CFSE peak dilution. As can be seen in Figure 4.11, T cells added to dendritic cells 
isolated from neutrophil-depleted mice exhibit a more pronounced peak dilution indicating that a 
greater amount of proliferation had occurred. 
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Figure 4.11. Evidence that dendritic cells from 1A8 depleted mice are more potent 
activators of T cells. Mice were treated with IgG or 1A8 antibodies, and lungs were collected at 
day 8 postinfection. Dendritic cells purified from lung digests were pulsed with OVA peptide 
antigen (2µg ml
-1
) for 4 hours. CFSE stained OT-II CD4
+
 T cells were added to the dendritic 
cells at a ratio of 10:1 T cells to DC. 4 days later, cells were collected and analyzed on a flow 
cytometer for CFSE peak dilution. Blue histogram shows CFSE dilution from CD4
+
 T cells 
added to DC isolated from IgG injected mice while the red histogram shows CFSE peak dilution 
from CD4
+
 T cells added to DC isolated from 1A8 treated, neutrophil depleted mice. 
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Discussion 
The importance of neutrophils in infection is well established. In addition to being the first cells 
to arrive at a site of infection or inflammation where they extrude various antimicrobial peptides 
and molecules, they can function as immunomodulatory cells that can influence an immune 
response well beyond the innate immunity stage. Here we show that the depletion of neutrophils 
followed by Toxoplasma infection led to rapid host mortality. This neutrophil-specific depletion 
had no bearing on parasite burden and any pathology in either lymphoid or non-lymphoid tissues 
with the exception of the lungs. Massive recruitment of cellular foci in the lungs was assayed and 
determined to be CD4
+
 T cells. This in turn led to an increased amount of cytokines in depleted 
and infected mice in the lungs and lung associated draining lymph nodes. This increased 
production of cytokine was due to overactive CD4
+
, CD8
+
 T cells and CD11b
+
 cells.  
 
A characteristic hallmark of neutrophils is their surface expression of Ly6G molecules (38). The 
role of neutrophils in vivo can be assayed by the use of Ly6G-specific monoclonal antibody to 
deplete these cells (32). Our laboratory has previously shown that treating mice with an anti-Gr-1 
antibody (Ly6C/G) during a Toxoplasma infection leads to impaired immunity characterized by a 
weaker Th1 response and uncontrolled tachyzoite replication (36). The Gr-1 surface marker can 
also be found on a recently described inflammatory monocyte population of cells in the context 
of Toxoplasma infection, as well as on plasmacytoid dendritic cells leading to mixed 
interpretations of anti-Gr-1 antibody depletion (38-40), thus leading us to re-examine our 
previously published data with the anti-Gr-1 antibody. 
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Neutrophil depletion also has major effects on host anti-microbial mechanisms and on the 
ensuing immune response during other infections. Gr-1
+
 depletion in mice infected with 
Leishmania infantum shows an effect for neutrophils on the early stages of the immune response 
but no effect late in infection (16). Also, depletion of neutrophils in Leishmania major infected 
mice led to exacerbated footpad lesions (18). However, in some infections neutrophils can 
contribute to disease. For example, infecting Gr-1
+
 depleted mice with Plasmodium berghei 
ANKA resulted in decreased mortality when compared to non-depleted and infected mice (41, 
42). Also, pulmonary infection of Gr-1
+
 depleted mice with Cryptococcus neoformans resulted in 
these mice surviving significantly longer than their non-depleted infected counterparts (43). 
Various infectious models including Toxoplasma, Mycobacterium tuberculosis and Candida 
albicans have highlighted the importance of early depletion of neutrophils when exacerbation of 
disease is considered, since late depletion of neutrophils had no effect on the outcome of disease 
(12, 36, 44). Neutrophils can also entrap Toxoplasma using neutrophil extracellular traps and a 
percentage of these parasites are killed when ascertained using the live-cell exclusion dye Sytox 
green (Chapter 3, Figure 3.5). Although depletion of neutrophils does not seem to affect parasite 
burden in infected mice, it can very well be that killing and or control mechanisms of the parasite 
is not limited to neutrophils and their extracellular traps and that the likelihood of redundancy in 
vivo of cellular functions is very high. 
 
Neutrophils exiting the bone marrow are normally believed to undergo apoptosis within 
approximately 24 hrs unless otherwise stimulated to prolong their survival by cytokines such as 
IL-6, G-CSF, TNF-α and IFN- (45-48). Since neutrophils carry within their cytoplasmic 
granules various toxic effector molecules, their apoptosis is followed by a rapid removal from 
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sites of infection or inflammation to minimize potential tissue damage associated with these 
molecules. This removal of apoptotic neutrophils is accomplished by phagocytic macrophages, 
and is important for the resolution of inflammation. Apoptotic neutrophils express specific 
markers on their surfaces that allows for their recognition by phagocytosing macrophages. For 
example, mannose-binding lectin (MBL) on macrophages can recognize pathogen-like apoptotic-
cell-associated molecular patterns (ACAMPs) on apoptotic neutrophils (49, 50). Also, one of the 
key “eat me” apoptotic cell markers is phosphatidylserine (PS) which is recognized by PS 
receptors (50). Evidence also suggests that macrophages that have phagocytosed other apoptotic 
cells acquire a pro-resolution phenotype, thus reducing the inflammatory response. (2, 51-54). 
This is in line with our data, where we hypothesize that in the absence of neutrophils (Ly6G 
treated mice), phagocytic cells are more “pro-inflammatory” due to the lack of apoptotic 
neutrophils in the milieu (Figure 4.12). This may explain our data showing that dendritic cells 
are able to present antigen better and more efficiently (Figure 4.11), which in turn may explain 
the increased number of CD4
+
 T cells (Figure 4.6). Also, an increased pro-inflammatory state at 
sites of infection can be expected to lead to activated and inflammatory phagocytes providing a 
possible explanation for our data showing more cytokine production in CD11b
+
 cells. Since the 
majority of IL-10 and INF- produced are coming from CD4+ T cells and CD8+ T cells, it would 
be interesting to know how depletions of T cells would affect onset of death in neutrophil-
depleted animals, an area of research currently being investigated in our laboratory. Taken 
together, our data suggest a model in which mice depleted of neutrophils succumb to 
Toxoplasma infection due to an unchecked and uncontrolled inflammatory response. 
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Figure 4.12. Phagocytes from neutrophil depleted and infected mice are more pro-
inflammatory. In the absence of neutrophils in 1A8 treated mice, no apoptotic neutrophils are 
present and as such, phagocytes have a more pro-inflammatory state. This leads to the activation 
of T cells and the up-regulation of cytokine production. In IgG treated and infected mice, 
apoptotic neutrophils are abound, and their eventual uptake by phagocytes leads to a pro-
resolution activation status of these phagocytes leading to down-regulation of T cell activity and 
inhibition of cytokine production. 
PMN             T cell      Apoptotic        Phagocyte 
                                        PMN 
Inhibition of T cell                                                             Activation of T cell 
function and activity                                                          function and activity 
                                                 Down-regulation of                                                  Up-regulation of 
                                                 cytokine production                                            cytokine production 
IgG treated                                                                     1A8 treated 
Pro-resolution phenotype                                               Inflammatory phenotype 
 
 163 
REFERENCES 
1. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev 
Immunol 6:173. 
2. Fox, S., A. E. Leitch, R. Duffin, C. Haslett, and A. G. Rossi. Neutrophil apoptosis: 
relevance to the innate immune response and inflammatory disease. J Innate Immun 
2:216. 
3. Dubey, J. P. 1998. Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 
28:1019. 
4. Dubey, J. P. 2007. The history and life-cycle of Toxoplasma gondii. In Toxoplasma 
gondii. The model apicomplexan: Perspective and methods. L. M. Weiss, and K. Kim, 
eds. Academic Press, San Diego, p. 1. 
5. Hill, D., and J. P. Dubey. 2002. Toxoplasma gondii: transmission, diagnosis and 
prevention. Clin. Microbiol. Infect. 8:634. 
6. Navia, B. A., C. K. Petito, J. W. M. Gold, E. S. Cho, B. D. Jordon, and J. W. Price. 1986. 
Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical 
and neuropathological findings in 27 patients. Ann. Neurol. 19:224. 
7. Reis e Sousa, C., S. Hieny, T. Scharton-Kersten, D. Jankovic, H. Charest, R. N. Germain, 
and A. Sher. 1997. In vivo microbial stimulation induces rapid CD40L-independent 
production of IL-12 by dendritic cells and their re-distribution to T cell areas. J. Exp. 
Med. 186:1819. 
8. Del Rio, L., B. A. Butcher, S. Bennouna, S. Hieny, A. Sher, and E. Y. Denkers. 2004. 
Toxoplasma gondii triggers MyD88-dependent and CCL2(MCP-1) responses using 
distinct parasite molecules and host receptors. J. Immunol. 172:6954. 
9. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-g: 
The major mediator of resistance against Toxoplasma gondii. Science 240:516. 
10. Stephens-Romero, S. D., A. J. Mednick, and M. Feldmesser. 2005. The pathogenesis of 
fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion 
strategy. Infect Immun 73:114. 
11. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, G. Del Sero, I. Nicoletti, G. 
Trinchieri, F. Bistoni, and P. Puccetti. 1997. Neutrophil production of IL-12 and IL-10 in 
candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 158:5349. 
12. Romani, L., A. Mencacci, E. Cenci, G. Del Sero, F. Bistoni, and P. Puccetti. 1997. An 
immunoregulatory role for neutrophils in CD4
+
 T helper subset selection in mice with 
candidiasis. J. Immunol. 158:2356. 
13. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to 
disseminated candidiasis in granulocytopenic mice. J Infect Dis 170:900. 
 164 
14. Barteneva, N., I. Theodor, E. M. Peterson, and L. M. de la Maza. 1996. Role of 
neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect 
Immun 64:4830. 
15. Tateda, K., T. A. Moore, J. C. Deng, M. W. Newstead, X. Zeng, A. Matsukawa, M. S. 
Swanson, K. Yamaguchi, and T. J. Standiford. 2001. Early recruitment of neutrophils 
determines subsequent T1/T2 host responses in a murine model of Legionella 
pneumophila pneumonia. J. Immunol. 166:3355. 
16. Rousseau, D., S. Demartino, B. Ferrua, J. F. Michiels, F. Anjuere, K. Fragaki, Y. Le 
Fichoux, and J. Kubar. 2001. In vivo involvement of polymorphonuclear neutrophils in 
Leishmania infantum infection. BMC Microbiol 1:17. 
17. Tacchini-Cottier, F., C. Zweifel, Y. Belkaid, C. Mukankundiye, M. Vasei, P. Launois, G. 
Milon, and J. Louis. 2000. An immunomodulatory function for neutrophils during the 
induction of a CD4
+
 Th2 response in BALB/c mice infected with Leishmania major. J. 
Immunol. 2628-2636. 
18. Chen, L., Z. H. Zhang, T. Watanabe, T. Yamashita, T. Kobayakawa, A. Kaneko, H. 
Fujiwara, and F. Sendo. 2005. The involvement of neutrophils in the resistance to 
Leishmania major infection in susceptible but not in resistant mice. Parasitol Int 54:109. 
19. Appleberg, R., A. G. Castro, and M. T. Silva. 1994. Neutrophils as effector cells of T-
cell-mediated. acquired immunity in murine listeriosis. Immunol. 83:302. 
20. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria 
defence in the liver, but not in the spleen or peritoneal cavity, as revealed by a 
granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259. 
21. Czuprynski, C. J., J. F. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. 
Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to 
Listeria monocytogenes infection. J. Immunol. 152:1836. 
22. Czuprynski, C. J., J. F. Brown, R. D. Wagner, and H. Steinberg. 1994. Administration of 
antigranulocyte monoclonal antibody RB6-8C5 prevents expression of acquired 
resistance to Listeria monocytogenes infection in previously immunized mice. Infect 
Immun 62:5161. 
23. Rogers, H. W., and E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific 
resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090. 
24. Bliss, S. K., L. C. Gavrilescu, A. Alcaraz, and E. Y. Denkers. 2001. Neutrophil depletion 
during Toxoplasma gondii infection leads to impaired immunity and lethal systemic 
pathology. Infect Immun 69:4898. 
25. Sayles, P. C., and L. J. Johnson. 1997. Exacerbation of toxoplasmosis in neutrophil 
depleted mice. Nat. Immun. 15:249. 
26. Bliss, S. K., A. J. Marshall, Y. Zhang, and E. Y. Denkers. 1999. Human 
polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines 
 165 
macrophage-inflammatory protein-1 alpha and -1 beta in response to Toxoplasma gondii 
antigens. J Immunol 162:7369. 
27. Del Rio, L., B. A. Butcher, S. Bennouna, S. Hieny, A. Sher, and E. Y. Denkers. 2004. 
Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and 
chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct 
parasite molecules and host receptors. J Immunol 172:6954. 
28. Bliss, S. K., B. A. Butcher, and E. Y. Denkers. 2000. Rapid recruitment of neutrophils 
containing prestored IL-12 during microbial infection. J Immunol 165:4515. 
29. Egan, C. E., W. Sukhumavasi, A. L. Bierly, and E. Y. Denkers. 2008. Understanding the 
multiple functions of Gr-1(+) cell subpopulations during microbial infection. Immunol 
Res 40:35. 
30. Nakano, H., M. Yanagita, and M. D. Gunn. 2001. CD11c(+)B220(+)Gr-1(+) cells in 
mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. 
Exp. Med. 194:1171. 
31. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two 
principal subsets with distinct migratory properties. Immunity 19:71. 
32. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use 
of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 
83:64. 
33. Bliss, S. K., Y. Zhang, and E. Y. Denkers. 1999. Murine neutrophil stimulation by 
Toxoplasma gondii antigen drives high level production of IFN-g-independent IL-12. J. 
Immunol. 163:2081. 
34. Burg, J. L., C. M. Grover, P. Pouletty, and J. C. Boothroyd. 1989. Direct and sensitive 
detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J 
Clin Microbiol 27:1787. 
35. Cassaing, S., Bessieres, M.H., Berry, A., Berrebi, A., Fabre, R., Magnaval, J.F. 2006. 
Comparison between two amplification sets for molecular diagnosis of Toxoplasmosis by 
reat-time PCR. J Clin Microbiol 44:720. 
36. Bliss, S. K., L. C. Gavrilescu, A. Alcaraz, and E. Y. Denkers. 2001. Neutrophil depletion 
during Toxoplasma gondii infection leads to impaired immunity and lethal systemic 
pathology. Infect. Immun. 69:4898. 
37. Gazzinelli, R. T., S. Hieny, T. Wynn, S. Wolf, and A. Sher. 1993. IL-12 is required for 
the T-cell independent induction of IFN-g by an intracellular parasite and induces 
resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115. 
38. Egan, C. E., W. Sukhumavasi, A. L. Bierly, and E. Y. Denkers. 2008. Understanding the 
multiple functions of Gr-1
+
 cell subpopulations during microbial infection. Immunologic 
Res. 40:35. 
 166 
39. Mordue, D. G., and L. D. Sibley. 2003. A novel population of Gr-1
+
-activated 
macrophages induced during acute toxoplasmosis. J. Leuk. Biol. 74:1. 
40. Robben, P. M., M. LaRegina, K. W.A., and L. D. Sibley. 2005. Recruitment of Gr-1+ 
monocytes is essential for control of acute toxoplasmosis. J. Exp. Med. 201:1761. 
41. Chen, L., Z. Zhang, and F. Sendo. 2000. Neutrophils play a critical role in the 
pathogenesis of experimental cerebral malaria. Clin Exp Immunol 120:125. 
42. Senaldi, G., C. Vesin, R. Chang, G. E. Grau, and P. F. Piguet. 1994. Role of 
polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the 
pathogenesis of svere murine malaria. Infect. Immun. 62:1144. 
43. Mednick, A. J., M. Feldmesser, J. Rivera, and A. Casadevall. 2003. Neutropenia alters 
lung cytokine production in mice and reduces their susceptibility to pulmonary 
cryptococcosis. Eur J Immunol 33:1744. 
44. Pedrosa, J., B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper. 
2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium 
tuberculosis infection of mice. Infect. Immun. 68:577. 
45. Payne, C. M., L. Glasser, M. E. Tischler, D. Wyckoff, D. Cromey, R. Fiederlein, and O. 
Bohnert. 1994. Programmed cell death of the normal human neutrophil: an in vitro model 
of senescence. Microsc. Res. Tech. 28:327. 
46. Lee, A., M. K. B. Whyte, and C. Haslett. 1993. Inhibition of apoptosis and prolongation 
of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54:283. 
47. Klein, J. B., M. J. Rane, J. A. Scherzer, P. Y. Coxon, R. Kettritz, J. M. Mathiesen, A. 
Buridi, and K. R. McLeish. 2000. Granulocyte-macrophage colony stimulating factor 
delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and 
extracellular signal-related kinase pathways. J. Immunol. 164:4286. 
48. Duncan, A. L., S. J. Leuenroth, P. Grutkoski, A. Ayala, and H. H. Simms. 2000. TNFa-
induced suppression of PMN apoptosis is mediated through IL-8 production. Shock 
14:284. 
49. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance 
of apoptotic cells regulates immune responses. Nat Rev Immunol 2:965. 
50. Hart, S. P., I. Dransfield, and A. G. Rossi. 2008. Phagocytosis of apoptotic cells. Methods 
44:280. 
51. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells 
undergoing apoptosis. Immunol Today 14:131. 
52. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson, and C. Haslett. 
1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell 
death in the neutrophil leads to its recognition by macrophages. J Clin Invest 83:865. 
 167 
53. Urban, B. C., N. Willcox, and D. J. Roberts. 2001. A role for CD36 in the regulation of 
dendritic cell function. Proc Natl Acad Sci U S A 98:8750. 
54. Stuart, L. M., M. Lucas, C. Simpson, J. Lamb, J. Savill, and A. Lacy-Hulbert. 2002. 
Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell 
maturation. J Immunol 168:1627. 
 
 
168 
 
 
 
 
 
 
Chapter 5 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
169 
 
Summary of findings 
Neutrophils play a major role in innate immunity and are usually considered to be short-lived 
cells with rapid anti-microbial effector functions against various microbial agents. Historically, 
PMN were viewed as “kamikaze” cells that home to sites of inflammation or infection in 
response to a chemotactic gradient where they discharge a host of toxic mediators followed 
immediately by their death through apoptosis (1). However, recent evidence shows that they are 
far more complicated than previously thought and that they play more nuanced roles in immune 
responses and immune modulation. An image of neutrophils is emerging as cells that can exert 
functions well beyond just killing, well beyond their own death, and well beyond the boundaries 
of innate immunity (2). The data in this thesis support this view. 
 
Data shown in Chapter 2 solidifies the role of neutrophils as antigen presenting cells. In this 
chapter, I have shown that neutrophils can upregulate molecules required for antigen 
presentation, namely MHC class II, CD80 and CD86. This upregulation of class II and co-
stimulatory molecules on the surface of neutrophils was dependent on contact with T cells, since 
experiments performed in the presence of a Transwell membrane that prohibits contact between 
both cell types, abrogated upregulation. After acquisition of antigen processing properties, I 
showed that PMN can indeed present antigen, by showing that they can uptake, process and 
present OVA antigen to OVA specific T cells. This antigen presentation led to the proliferation 
of T cells and to their activation, since T cells exhibited a naïve phenotype before being 
subjected to PMN antigen presentation and acquired an activated phenotype after antigen 
presentation. Interestingly, PMN antigen presentation led to differentiation by T cells toward a 
Th1 and Th17 phenotype, evidenced by the production of IFN- and IL-17 by PMN/T cell co-
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cultures. The cytokine production was entirely by T cells in these co-cultures; intracellular 
cytokine staining showed no evidence of cytokine production by neutrophils. The production of 
IL-17 by CD4
+
 T cells after antigen presentation by neutrophils was found to be both IL-6 and 
TGF- independent. 
 
Chapter 3 describes data showing how Toxoplasma gondii triggers the release of human and 
mouse neutrophil extracellular traps. Freshly isolated mouse neutrophils stimulated with PMA in 
culture produced NETs in a time-dependent fashion. The production of NETs from mouse 
neutrophils was a controlled process and not due to “cellular bursting”, since neutrophils isolated 
from LYSeGFP mice, that exhibit green fluorescence in every lysozyme positive cell, retained 
their GFP signal intracellularly. I also showed that Toxoplasma can induce NET formation in 
mouse neutrophils and that this induction was parasite-strain independent, since all three parasite 
types induced NET formation. Both NET induction in response to PMA and Toxoplasma was 
confirmed using a quantitative dsDNA assay and immunofluorescence microscopy. I also 
showed that NET induction in response to Toxoplasma is invasion independent since the use of 
cytochalasin D, a drug known to inhibit parasite invasion, did not have an effect on NET 
induction in neutrophils. Through the use of Sytox green, a live-cell exclusion dye, I was able to 
show that parasites trapped in NETs are susceptible to killing and that digestion of these NETs 
with DNAse left the parasites alive. By using differentiated HL-60 cells and freshly isolated 
human neutrophils from peripheral blood, I was able to demonstrate that human neutrophils also 
produce NETs in response to Toxoplasma. Inhibition of the phosphorylation of ERK using the 
MEK1/2 inhibitor, U0126, led to decreased NET formation in response to the parasite. The 
relevance of NET formation in vivo in response to Toxoplasma was elucidated in an intranasal 
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infection model. Lungs from mice infected intranasally with Toxoplasma had clear cellular 
infiltration loci that were shown to be both MPO and Toxoplasma positive. Measurement of 
BALF supernatants for dsDNA showed a massive increase in the amount of extracellular DNA, 
consistent with NET formation. 
 
Chapter 4 examines the role of neutrophils during a Toxoplasma infection. Treatment of mice 
with the 1A8 antibody (anti-Ly6G) completely depleted neutrophils in vivo. This depletion was 
monitored by flow cytometry, immunohistochemistry and peripheral blood smears. I found that 
neutrophil-depleted and infected mice succumb to Toxoplasma within 10 days post-infection. 
Given their sudden death, I decided to find out whether neutrophil-depleted and infected mice 
had any defect in their control of Toxoplasma. To my surprise, I found that neutrophil-depleted 
and infected mice had similar parasite burdens in all tissues tested when compared to their non-
depleted and infected counterparts. Also to my surprise, there was no obvious difference in tissue 
pathology between both groups in most lymphoid and non-lymphoid organs. However, extreme 
differences in both pathological and cytokine responses were observed in the lungs of mice. 
Mice depleted of neutrophils and infected with Toxoplasma exhibited an increased amount of 
cellular infiltration into the lungs. When assayed for cellular content, these infiltrates were 
determined to be mostly composed of CD4
+
 T cells. Interestingly, lung digests and BALF 
contained elevated numbers of B cells and macrophages in addition to the elevated numbers of 
CD4
+
 T cells. Given this increased number of cells, I decided to examine the cytokine profiles in 
these mice. Supernatants from BALF of depleted and infected mice showed increased levels of 
TNF-α and IL-12. Also, culture supernatants from STAg restimulated tracheobronchial lymph 
node cells exhibited elevated levels of IL-10, IL-12, TNF-α and IFN-. Interestingly, this 
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differential elevated cytokine response was shown to be localized to the lung, since restimulation 
assays using cells from spleens and mesenteric lymph nodes showed no difference between 
neutrophil-depleted and non-depleted and infected mice. Intracellular cytokine staining showed 
that the CD4
+
 and CD8
+ 
T cells are the source IFN- and IL-10. Similar staining performed on 
CD11b positive cells showed that they are the source of IL-12 and TNF-α. Flow cytometric 
analysis I performed showed that CD4
+
 T cells isolated from tracheobronchial lymph nodes in 
depleted mice  display increased levels of activation. I also found evidence for increased 
dendritic cell activation in the lungs of depleted and infected mice evidenced by their increased 
ability to induce more robust T cell proliferation. 
 
Future directions and unanswered questions 
Evidence for a role of neutrophils as antigen presenting cells had been reported before. Patients 
with chronic autoimmune disorders, rheumatoid arthritis and Wegner’s granulomatosis, have 
been shown to have neutrophils that are elevated for surface expression of MHC class II. 
Neutrophils from some of these patients have been also shown to have an upregulation of co-
stimulatory molecules, especially after cytokine stimulation (3-5). A more recent report showed 
that neutrophils can present OVA peptide-antigen (aa 323-339) to CD4
+
 OVA specific T cells 
(6). 
 
Data presented in Chapter 2 confirms this antigen presentation ability of neutrophils while at the 
same time is distinguished by the fact that it is the first report to show that neutrophils also have 
the ability to process whole antigen and present it to T cells. Also, it is the first report to show 
that neutrophil antigen presentation skews responding T cells towards a Th1 and Th17 profile. 
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What makes my Th17 skewing data interesting is the fact that it does not appear to require TGF-
 or IL-6. This is an area that needs to be investigated further as it would be very interesting to 
identify the neutrophil factors driving Th17 differentiation. It also remains to be elucidated as to 
what role if any neutrophils play in antigen presentation in vivo in light of their ability to do so in 
vitro. Given the wide-ranging ability of neutrophils to perform various functions, it would be 
interesting to know whether their APC abilities are needed in vivo in the context of disease if 
other APC, such as DC, are present and sufficiently priming T cells. A mouse model engineered 
to lack MHC molecules in PMN would be very useful here. 
 
In addition to their role in antigen presentation, ample evidence exists now showing that 
neutrophils can trap and/or kill pathogens by release of extracellular nuclear DNA (7). NETs 
formed as a result of the newly described neutrophil cell death process, NETosis, can trap and 
kill pathogens extracellularly (8). In Chapter 3 I show that NETs are formed in both mouse and 
human neutrophils as a result of Toxoplasma infection and that NET formation leads to the 
entrapment of Toxoplasma and that some parasites are killed by NETs. This is the first report to 
show that NETs are formed in response to Toxoplasma and that neutrophils can play a role in the 
extracellular killing and control of the parasite. The entrapment by NETs led to the killing of a 
certain percentage of the parasites (~25%) raising the possibility that the major role of NETs in 
the control of Toxoplasma gondii might not necessarily be the killing of the parasite, but more so 
the prohibiting of its spread. Since Toxoplasma is an obligate intracellular parasite, trapping it 
outside a cell will eventually lead to its demise. It remains to be elucidated whether entrapment 
by NETs prohibits infection of neighboring cells, in other words, whether the parasite can escape 
NET formation and continue to invade a host cell. This is a crucial question, given that I did not 
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observe complete parasite killing. Also, given that NET formation in response to Toxoplasma 
was not dependent on parasite invasion and that soluble tachyzoite antigen induced some NET 
formation, it is very likely that the parasitic trigger for NET formation is a secreted product. In 
experiments using cytochalasin D to block active invasion, I continued to observe NET 
formation. However, I cannot draw conclusions as to whether intracellularly infected neutrophils 
are still capable of undergoing NETosis. Although I saw no difference in NET formation in 
response to the parasite with or without cytochalasin D, it remains unclear whether NETosis 
observed was by infected or non-infected neutrophils since in the absence of cytochalasin D, not 
all cells are infected. Answering this question will help elucidate whether the parasite has 
mechanisms that can inhibit or interfere with NET formation and/or whether neutrophils 
themselves can carry out steps to counteract parasite manipulation of host mechanisms.  
 
Illuminating the role NETs can play in the control of Toxoplasma in vivo is an area that should 
be further investigated. Toxoplasma is well-known for the ability to infect any nucleated cell and 
by doing so can escape the extracellular milieu where NETs would have their parasite-
destructive effects. Since microbial infections trigger robust NET formation by neutrophils it 
would be interesting to know what role if any NETs play in contribution to disease and 
inflammation, especially in light of evidence that NETs are implicated in various autoimmune 
conditions. How NET formation contributes to parasite control or contributes to overall disease 
by possibly exacerbating inflammation is an area that needs further questioning. 
 
Conflicting reports have emerged over the role of neutrophils during Toxoplasma infection 
owing to the fact that historically anti-Ly6C/G (Gr-1) antibody had been the classical antibody of 
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choice for rendering mice neutropenic (9-12). This surface marker has since been described to 
occur on other cells as well, questioning the validity of data using anti-Gr-1 monoclonal antibody 
as the antibody of choice for neutrophil depletions. A more recent antibody, so far shown to be 
only neutrophil specific, is being used as the new gold standard for in vivo depletions (13). Using 
this antibody, I depleted neutrophils in vivo and infected with Toxoplasma resulting in lethal 
effects. 
 
Data shown in Chapter 4 demonstrates that in the absence of neutrophils, infection leads to a 
dysregulated immune response resulting in detrimental effects to the host. Mice depleted and 
infected exhibited abnormal pulmonary pathology characterized by dysregulated cytokine 
production and increased cellular infiltration. In these experiments, I observed increased 
cytokine production from cells isolated from neutrophil depleted and infected mice. Increased 
cytokine activity was attributed to CD4
+
 and CD8
+
 T cells as well as CD11b
+
 cells. It is possible 
that this dysregulated inflammatory response is due to the fact that in the absence of neutrophils 
at sites of inflammation, an immune response is not resolved as it normally would be due to lack 
of apoptotic neutrophils. During the normal process of resolution of inflammation, phagocytes 
take up apoptotic neutrophils and then undergo a down-modulatory shift, helping to resolve the 
immune response. In my model, lack of neutrophils led to an increased dendritic cell activation 
status as determined by increased T cell proliferation and increased cytokine production. This 
conclusion is based on DC:T cell proliferation studies, and no experiments were performed to 
assay for the activation status of DC between both depleted and non-depleted and infected 
groups. This is an issue that needs to be answered in the future. Also, since lung pathology seems 
to be mostly dependent on an infiltration of T cells, and increased cytokine production from T 
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cells is seen in depleted and infected mice, it would be very informative to co-deplete mice of 
both neutrophils and T cells to determine if an amelioration of lung pathology occurs or if host 
survival is lengthened. 
 
My depletion of neutrophils in vivo had no effect on Toxoplasma tissue burden in almost all 
tissues tested. This seems in apparent contrast to my NET data in Chapter 3 where neutrophils 
extruded traps that entangled Toxoplasma and led to some parasite killing. Although this may 
seem paradoxical, it is possible that by invading cells, the parasite escapes the effects of 
extracellular traps. Also, while parasite number was not apparently affected by neutrophil 
depletion, these studies were carried out in mice. Therefore, it is possible in other host species, 
NETs are important in controlling parasite number. In this regard, I found that human neutrophils 
were more responsive to NET formation than mouse neutrophils. 
 
Future work is required to address all the issues raised above. It is however very clear, that 
neutrophils are not just scavenging cells that travel to sites of infection and inflammation to 
destroy and kill only. Data generated by myself and by others show that neutrophils are major 
immunoregulatory cells that can influence and initiate immune responses. PMN are cells that are 
capable of multiple functions and are emerging as regulators of immune responses that play 
important roles in inflammation. 
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